Podcast: How to manage life after cancer treatment
Michael Roth, M.D.
Department of Pediatrics, Division of Pediatrics
About Dr. Michael Roth
Dr. Michael Roth graduated from New York University School of Medicine and completed a Pediatrics residency and Pediatric Hematology/Oncology fellowship at the Albert Einstein College of Medicine. He is currently a professor of pediatrics at The University of Texas MD Anderson Cancer Center. Dr. Roth specializes in caring for children and adolescents with leukemia and lymphoma and he is the Director of the Childhood Cancer Survivorship Program. Dr. Roth’s clinical research focuses on improving outcomes for adolescents and young adults (AYA) with cancer and he is the chair of the Children’s Oncology Group AYA Oncology Discipline Committee. In addition, Dr. Roth is the co-director of the AYA Program and the director of the Survivorship program at The University of Texas MD Anderson Cancer Center.
Present Title & Affiliation
Primary Appointment
Professor, Department of Pediatrics - Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Medical Director, Survivorship Program, Department of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, Houston, Texas
Co-Director, Adolescent and Young Adult (AYA) Oncology Program, Department of Pediatrics - Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Director, Childhood Cancer Survivorship Programs, Department of Pediatrics - Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Professor, Department of Pediatrics - Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas
Clinical Interests
I am an academic pediatric hematologist/oncologist and a clinical and translational researcher focused on improving cancer care delivery and clinical outcomes for adolescents and young adults (AYAs) with cancer. My clinical research focuses on increasing AYA participation on cancer clinical trials, improving long-term health-related quality of life for children and AYA cancer survivors, and decreasing anthracycline-induced cardiotoxicity. My translational research focuses on studying the feasibility and efficacy of utilizing novel, targeted anti-cancer agents in adolescent and young adult (AYA) malignancies, with the goal of bringing new precision agents to pediatric and collaborative AYA clinical trials.
I am the Director of the Childhood Cancer Survivorship Program and the co-Director of the Adolescent and Young Adult Program at MD Anderson Cancer Center, where I oversee and ensure multidisciplinary delivery of clinical care and support resources for patients. I am also the Chair of the AYA Oncology Discipline Committee within the Children’s Oncology Group (COG) and lead the AYA Responsible Investigator Network, which includes >120 investigators from COG sites around the world, all focused on enhancing AYA clinical trial enrollment. In these activities, I assemble local and national stakeholders, set novel research agendas and strategies, and advance priorities for quality oncology care delivery for this patient population.
Education & Training
Degree-Granting Education
| 2006 | New York University School of Medicine, New York, New York, US, MD |
| 2002 | Brandeis University, Waltham, Massachusetts, US, BA in Biology |
Postgraduate Training
| 2010-2012 | Research Fellowship, Laboratory of Cell Biology, Albert Einstein College of Medicine, Bronx, New York |
| 2009-2012 | Clinical Fellowship, Pediatrics Hematology/Oncology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York |
| 2006-2009 | Intern & Resident, Pediatrics, Albert Einstein College of Medicine, Bronx, New York |
Licenses & Certifications
| 2024 | Controlled Substance Registration Certificate - Drug Enforcement Administration |
| 2024 | Georgia Composite Medical Board License |
| 2024 | Louisiana State Board of Medical Examiners |
| 2024 | Washington State Department of Health |
| 2024 | Oklahoma Board of Medical Licensure |
| 2024 | Arizona Board of Medical Examiners |
| 2024 | Alabama Board of Medical Examiners |
| 2024 | Tennessee Board of Medical Examiners |
| 2024 | Mississippi State Board of Medical Licensure |
| 2017 | Advanced Cardiovascular Life Support |
| 2017 | Texas Medical Board License |
| 2013 | American Board of Pediatrics |
| 2009 | American Board of Pediatrics |
| 2009 | New York State Education Department |
| 2006 | Pediatric Advanced Life Support |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Pediatrics - Patient Care, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2017 - 2023
Administrative Appointments/Responsibilities
Deputy Division Head, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present
Director, Childhood Cancer Survivorship Program, The University of Texas MD Anderson Cancer Center, Houston, Texas
Co-Director, Adolescent and Young Adult (AYA) Program, The University of Texas MD Anderson Cancer Center, Houston, Texas
Medical Director, Cancer Survivorship, The University of Texas MD Anderson Cancer Center, Houston, Texas
Extramural Institutional Committee Activities
Member, REACH Executive Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Term Tenure Hiring Panel, MD Anderson Cancer Center, 2024 - Present
Member, Clinical Effectiveness Advisory Committee, MD Anderson Cancer Center, 2023 - Present
Chair, Cancer Survivorship Steering Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Pediatrics Team Leaders Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Professionalism Ambassador, Division Professionalism Ambassador Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Cancer Survivorship Steering Committee, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Member, Transparency Governance Council, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2019 - Present
Co-leader, Pediatrics Team Leaders Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2022
Co-Leader, AYA Survivorship Clinical and Research Team, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Pediatric Hematology/Oncology Program Evaluation Committee, The University of Texas MD Anderson Cancer Center Children's Cancer Hospital, The University of Texas MD Anderson Cancer Center, 2017 - Present
Co-leader, Survivorship Clinical and Research Team, The University of Texas MD Anderson Cancer Center Children's Cancer Hospital, The University of Texas MD Anderson Cancer Center, 2017 - Present
Editorial Activities
Reviewer, Clinician Educator Award Review Group, American Society of Pediatric Hematology/Oncology, 2016 - 2017
Honors & Awards
| 2025 - Present | Robert M. Chamberlain Distinguished Mentor Award, The University of Texas MD Anderson Cancer Center |
| 2025 - Present | Leading Mentor in Cancer Prevention Honorable Mention, MD Anderson Cancer Center |
| 2025 - Present | Division of Pediatrics “Research Excellence ” honoree, University of Texas MD Anderson Cancer Center |
| 2023 | NCI Director's Award, NCI NCTN AYA Working Group, for Oversight of Programmatic Vision-Scientific, NCI |
| 2020 | Texas Super Doctors, Texas Monthly |
| 2018 | Faculty Excellence in Prevention Outreach, MD Anderson Cancer Center |
| 2017 | New York Super Doctors- Best Doctors |
| 2014 | Henry L. Moses Award in Basic Science, Montefiore Medical Center |
| 2013 - 2016 | New York Super Doctors Rising Stars |
| 2013 | Lewis Fraad Award for Excellence in the Teaching of Residents, Children’s Hospital at Montefiore |
| 2013 | Society for Pediatric Research Inductee |
| 2012 | Pediatric Research Day Poster Presentation Award, AECOM |
| 2011 | American Society of Hematology Abstract Achievement Award, American Society of Hematology |
| 2011 | Leo M. Davidoff Society Inductee for Outstanding Achievement in Medical Student Education |
| 2009 - 2010 | Resident Teaching Award, Children’s Hospital at Montefiore |
| 2007 - 2009 | Medical Student Teaching Award, AECOM |
| 2007 - 2008 | Best Resident Educator Award, Children’s Hospital at Montefiore |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2019. Improving Long-Term Cardiac Outcomes in Childhood and AYA Cancer Survivors. Conference. Improving Long-Term Cardiac Outcomes in Childhood and AYA Cancer Survivors. Houston, TX, US.
- 2018. Surviving Childhood Cancer: Improving Long-Term Outcomes. Conference. Surviving Childhood Cancer: Improving Long-Term Outcomes. Houston, TX, US.
- 2018. Surviving Childhood Cancer: Improving Long-Term Outcomes. Conference. Surviving Childhood Cancer: Improving Long-Term Outcomes. Houston, TX, US.
- 2017. The Division of Pediatrics Research Database. Conference. The Division of Pediatrics Research Database. Houston, TX, US.
- 2017. Survivorship Strategic Vision. Conference. Survivorship Strategic Vision. Houston, TX, US.
Regional Presentations
- 2025. Identifying and Addressing Disparities in Care & Outcomes for AYA Patients Diagnosed with Cancer. Invited. Cedars-Sinai Cancer Center: Adolescents and Young Adult Cancer Fall Conference 2025. Los Angeles, CA, US.
- 2025. Implementing a Novel Training Program to Support Integration of Cancer Survivorship into Primary Care Practice. Invited. Texas Primary Care Consortium Summit. Austin, Texas, US.
- 2025. Cancer Survivorship: Supporting Patients Beyond Treatment. Invited. Christus Health Clinical Pearls Series, Texas, US.
- 2025. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. 39th Annual Western Regional Oncology Conference. El Paso, TX, US.
- 2024. Optimizing Enrollment of Adolescents and Young Adults onto Cancer Clinical Trials. Invited. UC Davis AYA Symposium. Sacramento, CA, US.
- 2024. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. Children’s Mercy Visiting Professor Program. Kansas City, MO, US.
- 2023. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. Texas Children’s Grand Rounds. Houston, TX, US.
- 2023. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. Northwestern Lurie Cancer Center Grand Rounds. Chicago, IL, US.
- 2023. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. Tampa General Grand Rounds. Tampa Bay, FL, US.
- 2023. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. Rutgers Cancer Institute Survivorship Retreat. New Brunswick, NJ, US.
- 2023. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. Westchester Medical Center Grand Rounds. Hawthorne, NY, US.
- 2021. Opportunities to assess and address disparities in care, health-related quality of life and survival for adolescents and young adults diagnosed with cancer. Conference. UT Austin Cancer Center Retreat. Austin, TX, US.
- 2019. Improving Long-Term Cardiac Outcomes in Childhood and AYA Cancer Survivors. Conference. Department of Cardiology Grand Rounds. Houston, TX, US.
- 2018. Surviving Childhood Cancer: Improving Long-Term Outcomes. Conference. Division of Internal Medicine Grand Rounds. Houston, TX, US.
- 2017. The Division of Pediatrics Research Database. Conference. Division of Pediatrics Grand Rounds. Houston, TX, US.
- 2017. Survivorship Strategic Vision. Conference. Division of Pediatrics Grand Rounds. Houston, TX, US.
- 2016. Caring for Survivors of Childhood Cancer, Invited Speaker. Invited. Summer Undergraduate Mentorship Program. Bronx, NY, US.
- 2016. Paul Calabresi Clinical Oncology Presentation. Conference. Paul Calabresi Clinical Oncology Presentation. Bronx, NY, US.
- 2016. Caring for Survivors of Childhood Cancer, Invited Speaker. Invited. Summer Undergraduate Mentorship Program. Bronx, NY, US.
- 2016. Improving Long-Term Outcomes for Survivors of Childhood Cancer. Conference. Grand Rounds. Bronx, NY, US.
- 2016. Improving Long-Term Outcomes for Children with Medical Illnesses: Lessons from Survivors of Childhood Cancer. Conference. Grand Rounds. Bronx, NY, US.
- 2016. How to Be a Mentor: Mentor: Mentee Perspectives. Break Out Session Panel Member. Conference. Pediatric Research Day. Bronx, NY, US.
- 2016. Transitioning From Fellowship to Becoming an Attending. Conference. Fellow's Research Course. Bronx, NY, US.
- 2016. Paul Calabresi Clinical Oncology Presentation. Conference. Paul Calabresi Clinical Oncology Presentation. Bronx, NY, US.
- 2015. Career Development and Goal Setting, Invited Speaker. Invited. Summer Undergraduate Mentorship Program. Bronx, NY, US.
- 2015. Approach to Anemia. Conference. Department of Pediatrics. Bronx, NY, US.
- 2015. The Feasibility and Utility of Antibody-Mediated Therapy in Osteosarcoma. Conference. Pediatric Faculty Research Conference. Bronx, NY, US.
- 2015. Ethics Conference: Refusal of Treatment in Pediatric Oncology. Conference. Hospitalist Lecture Series. Bronx, NY, US.
- 2014. Resident Research Workshops. Conference. Resident Research Workshops, October-February 2014-2015. Bronx, NY, US.
- 2014. Career Development and Goal Setting: Invited Speaker. Invited. Summer Undergraduate Mentorship Program. Bronx, NY, US.
- 2014. Oncologic Emergencies. Conference. Pediatric Critical Care Fellow Lecture Series. Bronx, NY, US.
- 2014. The Anti-Leukemia Effect of a Novel Thrombopoietin Agonist. Conference. Pediatric Faculty Research Conference. Bronx, NY, US.
- 2014. Approach to Anemia. Conference. Department of Pediatrics. Bronx, NY, US.
- 2014. Transitioning From Fellowship to Becoming an Attending. Conference. Sub-specialty Fellows' Research Course. Bronx, NY, US.
- 2014. Delivering bad news: The use of standardized patient encounters to improve communication skills in pediatric oncology fellows. Poster presentation. Poster. Davidoff Education Day. Bronx, NY, US.
- 2014. Oncologic Emergencies. Conference. Pediatric Critical Care Fellow Lecture Series. Bronx, NY, US.
- 2013. The Anti-Leukemia Effect of a Novel Thrombopoietin Agonist. Conference. Hematology Grand Rounds. Bronx, NY, US.
- 2013. Paul Calabresi Clinical Oncology Presentation. Conference. Paul Calabresi Clinical Oncology Presentation. Bronx, NY, US.
- 2013. How to Approach Anemia, Guest Lecture. Invited. Department of Family Medicine. Bronx, NY, US.
- 2013. The Road to Survivorship, Invited Speaker. Invited. Summer Undergraduate Mentorship Program. Bronx, NY, US.
- 2013. Improving Long-Term Outcomes for Children with Medical Illnesses: Lessons from Survivors of Childhood Cancer. Conference. Grand Rounds. Bronx, NY, US.
- 2013. Transitioning From Fellowship to Becoming an Attending. Conference. Sub-specialty Fellows' Research Course. Bronx, NY, US.
- 2013. Resident Research Core Curriculum Talks. Conference. Resident Research Core Curriculum Talks. Bronx, NY, US.
- 2012. Transition of Care for Pediatric Hematology and Oncology Patients. Invited Speaker. Invited. AAP NY Chapter 3. Valhalla, NY, US.
- 2012. Acute Myeloid Leukemia in Infancy. Conference. Grand Rounds. Bronx, NY, US.
- 2012. Eltrombopag inhibits leukemia cell growth via a reduction of intracellular iron and induction of differentiation. Work in Progress. Conference. Work in Progress, Department of Cell Biology. Bronx, NY, US.
- 2012. Platform Presentation: The Utility of the Urine Pneumococcal Antigen Test in Children with Sickle Cell Disease. Conference. Philadelphia, PA, US.
- 2011. How to Approach Anemia. Conference. Department of Family Medicine. Bronx, NY, US.
- 2011. Workshop for Young Adult Cancer Survivors, Invited Speaker. Invited. Department of Family Medicine. Bronx, NY, US.
- 2011. Sickle Cell Anemia. Conference. Physician's Assistant Post-Graduate Residency Program. Bronx, NY, US.
- 2011. Survivorship in Pediatric Oncology. Conference. Summer Student Lecture Series. Bronx, NY, US.
- 2011. Atypical Teratoid/Rhabdoid Tumors. Conference. Case Presentation and Review of the Literature. Bronx, NY, US.
- 2011. The Development of a Pediatric Vascular Access Team. Poster. Research Day. Bronx, NY, US.
- 2011. Fever and Neutropenia: Lessons Learned from the Past. Conference. Joint Pediatric Hematology/Oncology/Infectious Disease Conference. Bronx, NY, US.
- 2011. Debriefing Sessions: Coping with the Loss of a Patient. Conference. Pediatric Resident Education Series. Bronx, NY, US.
- 2011. Meeting the Needs of Survivors of Childhood Cancer. Conference. Focus Group. Bronx, NY, US.
- 2011. Poster Presentation: Stem Cell Transplantation for Children with Sickle Cell Anemia: Factors Associated with Parent and Patient Interest. Poster. 53rd Annual American Society of Hematology Meeting. San Diego, CA, US.
- 2011. Platform Presentation: The anti-leukemic Effect of Eltrombopag. Conference. Pediatric Research Day. Bronx, NY, US.
- 2010. We Can’t Fix It. When Hope for a Cure Fades Overnight. Conference. Schwartz Rounds. Bronx, NY, US.
- 2010. Intra-abdominal Tumors in Children. Conference. Physician's Assistant Post-Graduate Residency Program. Bronx, NY, US.
- 2010. Debriefing Sessions: Coping with the Loss of a Patient. Conference. Pediatric Resident Education Series. Bronx, NY, US.
- 2009. An Assessment of the Current State of Palliative Care Education during Pediatric Hematology/Oncology Fellowship Training. Conference. Pediatric Resident Education Series. Bronx, NY, US.
- 2009. Bone Marrow Failure Syndromes: A 3 year old patient with Revesz Syndrome. Conference. Pediatric Resident Education Series. Bronx, NY, US.
- 2009. Sickle Cell Anemia. Conference. Pediatric Resident Education Series. Bronx, NY, US.
- 2009. Poster Presentation: An Assessment of the Current State of Palliative Care Education during Pediatric Hematology/Oncology Fellowship Training. Poster. 22nd Annual ASPHO Meeting. San Diego, CA, US.
- 2009. The Resident Research Initiative. Conference. Pediatric Resident Education Series. Bronx, NY, US.
- 2009. Debriefing Sessions: Coping with the Loss of a Patient. Conference. Pediatric Resident Education Series. Bronx, NY, US.
- 2008. Poster Presentation: Pediatric Oncologists' Views Toward the Use of Complementary and Alternative Medicine in Children with Cancer. Poster. Honolulu, HI, US.
- 2007. A 10 year old Patient with Monosomy 7 AML. Conference. Pediatric Resident Education Series. Bronx, NY, US.
National Presentations
- 2025. Collaborating to Increase Clinical Trial Participation in AYA Cancer Patients. Invited. AACR. Chicago, IL, US.
- 2025. Treatment and Care Models in Active Treatment. Invited. Lymphoma Research Foundation AYA Workshop. Jersey City, NJ, US.
- 2025. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Invited. Western Regional Oncology Conference. El Paso, TX, US.
- 2024. Optimizing enrollment of adolescents and young adults onto cancer clinical trials. Invited. AYA Symposium - Engaging Adolescent and Young Adults in Health Research, US.
- 2024. Disparities in Health Outcomes for Survivors of Adolescent and Young Adult Cancer. American Society of Preventive Oncology. Invited. ASPO’s 48th Annual Meeting. Chicago, IL, US.
- 2023. Disparities in Adolescent and Young Adult Cancer Care and Outcomes. AYA-O POWER Education Series. AYA-O POWER, US.
- 2022. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Conference. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Seattle, WA, US.
- 2022. Keynote Address: Delivering High-Quality Care to Adolescents & Young Adults with Cancer. Conference. Keynote Address: Delivering High-Quality Care to Adolescents & Young Adults with Cancer. Memphis, TN, US.
- 2022. Children’s Oncology Group AYA Trials and Studies. Conference. Children’s Oncology Group AYA Trials and Studies. Chicago, IL, US.
- 2022. Opportunities to Improve Health, Quality of Life, and Survival for AYAs with Cancer (Virtual Presentation). Invited, US.
- 2022. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Conference. Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer. Los Angeles, CA, US.
- 2022. Developments in Adolescent and Young Adult (AYA) Trials in NCORP. Conference. Developments in Adolescent and Young Adult (AYA) Trials in NCORP. Betjesda, MD, US.
- 2022. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials. Conference. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials. San Antonio, TX, US.
- 2021. Challenges of AYA Enrollment in Clinical Trials: Understanding and Addressing Barriers to Enrolment. Conference. 2021 Adolescent and Young Adult (AYA) Symposium [Virtual Platform], US.
- 2021. Challenges of AYA enrollment on clinical trials: Understanding and addressing barriers to enrollment. Conference. Challenges of AYA enrollment on clinical trials: Understanding and addressing barriers to enrollment. Columbus, OH, US.
- 2021. Multi-disciplinary Panel: An Interprofessional Approach to AYA Program Development. Conference. Multi-disciplinary Panel: An Interprofessional Approach to AYA Program Development. Houston, TX, US.
- 2020. Special Session: Optimizing care, outcomes and enrollment for AYAs through virtual engagement. Conference. Special Session: Optimizing care, outcomes and enrollment for AYAs through virtual engagement, US.
- 2020. COG AYA Oncology Discipline Committee Retreat. Conference. COG, US.
- 2020. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials at NCORP Sites. Conference. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials at NCORP Sites. Gastonia, NC, US.
- 2020. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials. Conference. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials. San Antonio, TX, US.
- 2020. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials at NCORP Sites. Conference. Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials at NCORP Sites. Gastonia, NC, US.
- 2020. Opportunities to Improve Long-Term Outcomes for Children, Adolescents, and Young Adults with CNS Tumors. Conference. Opportunities to Improve Long-Term Outcomes for Children, Adolescents, and Young Adults with CNS Tumors. Dallas, TX, US.
- 2019. Achieving an NCORP Priority: Enrolling Adolescents and Young Adult (AYA) Patients on Clinical Trials. Conference. NCI Community Oncology Research Program. Bethesda, MD, US.
- 2019. State of AYA Oncology Outcomes and Clinical Trial Enrollment… and Opportunities for Collaboration. Conference. State of AYA Oncology Outcomes and Clinical Trial Enrollment… and Opportunities for Collaboration. Chicago, IL, US.
- 2019. AYAs Cancer Prevention and Supportive Care Studies: Opportunities. Conference. AYAs Cancer Prevention and Supportive Care Studies: Opportunities. Bethesda, MD, US.
- 2019. AYAs and Clinical Trials: Are all AYAs created Equal?. Conference. NCI Community Oncology Research Program. Bethesda, MD, US.
- 2019. The AYA Responsible Investigator Network. Conference. The AYA Responsible Investigator Network. Chicago, IL, US.
- 2019. Understanding and Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials. Conference. Understanding and Addressing Barriers to AYA Enrollment onto Cancer Clinical Trials. Chicago, IL, US.
- 2019. Improving Access to Clinical Trials for the Adolescent and Young Adult (AYA) Cancer Patient. Conference. Improving Access to Clinical Trials for the Adolescent and Young Adult (AYA) Cancer Patient. San Diego, CA, US.
- 2019. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. Conference. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. Denver, CO, US.
- 2018. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. Conference. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. St. Louis, MO, US.
- 2018. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. Conference. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. Dallas, TX, US.
- 2017. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. Conference. COG Spring Meeting. St. Louis, MO, US.
- 2017. CML Working Group Session: Late effects in children and adolescents diagnosed with CML. Conference. COG Spring Meeting. St. Louis, MO, US.
- 2017. CML Working Group Session: Late effects in children and adolescents diagnosed with CML. Conference. CML Working Group Session: Late effects in children and adolescents diagnosed with CML. St. Louis, MO, US.
- 2017. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. Conference. Breakout Session: Adolescent and Young Adult Clinical Trial Enrollment. St. Louis, MO, US.
- 2017. Poster Presentation: Introducing C-Myc into transformed mesenchymal stem cells and osteoblasts to recapitulate the osteosarcoma phenotype. Conference. AACR. Washington, DC, US.
- 2017. Poster Presentation: Stage 1 evaluation of multi-receptor tyrosine-kinase inhibitor lenvatinib in osteosarcoma patient derived mouse xenograft models. Conference. AACR. Washington, DC, US.
- 2017. Poster Presentation: Skp2 is a therapeutic target for human osteosarcoma and its expression is inhibited by flavokawain A, a kava chalcone. Conference. AACR. Washington, DC, US.
- 2017. Poster Presentation: Identifying circulating tumor DNA in patients with osteosarcoma. Conference. AACR. Washington, DC, US.
- 2017. Poster Presentation: ICAM-1 (CD54) is involved in the osteogenic differentiation of mesenchymal stem cells and affects the progression of osteosarcoma cells. Conference. AACR. Washington, DC, US.
- 2016. Poster Presentation: The Effect of rhBMP-2 on in vitro Osteosarcoma Tumorigenesis and on Pulmonary Growth and Development. Conference. Poster Presentation: The Effect of rhBMP-2 on in vitro Osteosarcoma Tumorigenesis and on Pulmonary Growth and Development. New Orleans, LA, US.
- 2016. Poster Presentation: Evaluation of CD47 Expression and Effects of CD47-SIRPalpha Fusion Protein in Patients with Osteosarcoma. Conference. AACR. New Orleans, LA, US.
- 2016. Poster Presentation: HHLA2, a Novel Member of the B7 Family of Inhibitory Ligands, is Highly Expressed in Osteosarcoma. Conference. AACR. New Orleans, LA, US.
- 2016. Poster Presentation: Immune Infiltration and PD-L1 Expression in the Tumor Microenvironment are Prognostic in Osteosarcoma. Conference. AACR. New Orleans, LA, US.
- 2016. Poster Presentation: Pediatric Oncology Provider Views on Biopsying Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling. Conference. ASCO. Chicago, IL, US.
- 2016. Platform Presentation: Perception and Communication of Life Expectancy and Prognosis in Sickle Cell Disease: A Multi-Center Study of Adolescents with SCD, their Parents, and Pediatric Hematologists. Conference. ASPHO. Minneapolis, MN, US.
- 2016. AYA Open Sessions: Adolescent and Young Adult Clinical Trial Enrollment at CCOP/NCORP Sites. Conference. COG Fall Meeting. Atlanta, GA, US.
- 2016. Workshop Chair: Everything You Need to Know About Enrolling AYAs on Clinical Joints. Conference. COG Fall Meeting. Atlanta, GA, US.
- 2016. Poster Presentation: Flavokawain A and B from Kava Extract Exhibits Low Toxicity and Up-Regulates Tumor Suppressor miRNAs in Human Osteosarcoma Cells. Conference. AACR. New Orleans, LA, US.
- 2016. Poster Presentation: Expanded Access Programs Require More than Compassion: Challenges in Pediatric Oncology. Conference. ASPHO. Minneapolis, MN, US.
- 2016. Poster Presentation: The Role of Fine Needle Aspiration in Diagnosing Pediatric Malignancies. Conference. ASPHO. Minneapolis, MN, US.
- 2016. AYA Open Session: Adolescent and Young Adult Clinical Trial Enrollment at CCOP/NCORP Sites. Conference. AYA Open Session: Adolescent and Young Adult Clinical Trial Enrollment at CCOP/NCORP Sites. Atlanta, GA, US.
- 2016. Workshop Chair: Everything You Need to Know About Enrolling AYAs on Clinical Trials. Conference. Workshop Chair: Everything You Need to Know About Enrolling AYAs on Clinical Trials. Atlanta, GA, US.
- 2015. Poster Presentation: The PD-1:PD-1L Pathway in the Context of the Osteosarcoma Tumor Microenvironment. Conference. AACR. Philadelphia, PA, US.
- 2015. Workshop: Teaching Communication Skills During Fellowship Training. Conference. Workshop: Teaching Communication Skills During Fellowship Training. San Diego, CA, US.
- 2015. Poster Presentation: Surface Markers of Osteoblastic Differentiation from Mesenchymal Stem Cells. Conference. PAS. San Diego, CA, US.
- 2015. Workshop: Teaching Communication Skills During Fellowship Training. Conference. Association of Pediatric Program Directors Meeting. San Diego, CA, US.
- 2015. Poster Presentation: Utilizing Cell Surface Markers to Define the Stages of Osteoblast Differentiation. Conference. AACR. Philadelphia, PA, US.
- 2014. Poster Presentation: Provider Management of Lung Metastases in Patients with Osteosarcoma. Conference. AACR. San Diego, CA, US.
- 2014. Communicating prognosis in sickle cell disease: addressing the future to facilitate informed decisions. Conference. Sickle Cell Disease Society of America. Baltimore, MD, US.
- 2014. Poster Presentation: Communicating Prognosis in Sickle Cell Disease: Addressing the future to Facilitate Informed Decisions. Conference. ASPHO. Chicago, IL, US.
- 2014. Poster Presentation: Elucidating Expression Patterns of GPNMB and Potential Anti-Tumor Effects of the Antibody-Drug Conjugate Glembatumumab Vedotin (CDX-011) in Human Osteosarcoma Samples. Conference. AACR. San Diego, CA, US.
- 2013. Poster Presentation: Integrative Treatment of Myeloma. Conference. Society for Integrative Oncology. Vancouver, Cananda, US.
- 2012. Platform Presentation: The Utility of the Urine Pneumococcal Antigen Test in Children with Sickle Cell Disease. Conference. Eastern SPR. Philadelphia, PA, US.
- 2012. Poster Presentation: Parent and Adolescent Beliefs on the Long-Term Impact of Sickle Cell Disease. Conference. Pediatric Academic Societies. Boston, MA, US.
- 2011. Platform Presentation: The anti-leukemic Effect of Eltrombopag. Pediatric Research Day. Conference. Montefiore Medical Center. Bronx, NY, US.
- 2011. Poster Presentation: Stem Cell Transplantation for Children with Sickle Cell Anemia: Factors Associated with Parent and Patient Interest. Conference. American Society of Hematology. San Diego, CA, US.
- 2009. Poster Presentation: An Assessment of the Current State of Palliative Care Education during Pediatric Hematology/Oncology Fellowship Training. Conference. ASPHO. San Diego, CA, US.
- 2008. Poster Presentation: Pediatric Oncologists’ Views Toward the Use of Complementary and Alternative Medicine in Children with Cancer. Conference. Pediatric Academic Society. Honolulu, HI, US.
International Presentations
- 2024. Best practices in telehealth care for AYA cancer survivors: What we know and where we’re going. Invited. 6th Global Adolescent and Young Adult Cancer Congress. Melbourne, AU.
- 2024. Addressing Barriers to AYA Cancer Clinical Trial Enrollment:Children’s Oncology Group Strategy. Invited. 6th Global Adolescent and Young Adult Cancer Congress. Melbourne, AU.
- 2024. Improving Adolescent and Young Adult (AYA) Cancer Clinical Trial Enrollment in the United States. Invited. 2024 CCLG Annual Conference. Milton Keynes, GB.
- 2023. Marginalized and Minoritized: Disparities and Unequal Treatment in AYA Oncology. Invited. 5th Global Adolescent and Young Adult Cancer Congress, US.
- 2023. Identifying and Addressing Barriers to AYA Cancer Clinical Trial Enrollment: The United States Perspective. Invited. 5th Global Adolescent and Young Adult Cancer Congress, US.
- 2021. Addressing the Paucity of AYA Clinical Trials Through a Pediatric-Adult Partnership. Invited. Global AYA Cancer Congress, US.
- 2021. Increasing Enrollment of Adolescents and Young Adults with Cancer in Clinical Trials. Panelist. SIOP, US.
- 2021. Acute Toxicities in AYAs Treated for Acute Lymphoblastic Leukemia. CLEAR Meeting. Invited. CLEAR Meeting. Copenhagen, DK.
Grant & Contract Support
| Date: | 2025 - 2029 |
| Title: | Cancer-Related Fatigue and its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-Exercise Intervention |
| Funding Source: | CPRIT |
| Role: | Co-I |
| ID: | RP250190 |
| Date: | 2025 - 2027 |
| Title: | Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant |
| Funding Source: | NIH |
| Role: | Site PI |
| ID: | 1R34CA297498-01 |
| Date: | 2024 - 2029 |
| Title: | Impact of accelerated cardiac aging in adolescent and young adult cancer survivors: the DANCES (Diversity in AYA Cancer Survivors) study |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | PAR-21-322 NCI-R01 |
| Date: | 2023 - 2025 |
| Title: | Expansion of HPV Vaccination Among Survivors of Childhood Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | PP230061 |
| Date: | 2023 - 2026 |
| Title: | Children’s Oncology NCI Community Oncology Research Program (NCORP) Research Base |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | UG1CA189955 |
| Date: | 2023 - 2024 |
| Title: | Partnering to Advance Psycho-Oncology Services for Underrepresented Adolescents and Young Adults with Cancer |
| Funding Source: | PCORI |
| Role: | Consult |
| ID: | 400021 |
| Date: | 2022 - 2024 |
| Title: | The Young- Onset Rectal or Colon (YOU-ROC) Cancer Survivorship Study |
| Funding Source: | MDACC Survivorship IRG |
| Role: | CO-I |
| Date: | 2022 - 2026 |
| Title: | Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors (Years 3 and 4) |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | R01CA261750 |
| Date: | 2022 - 2024 |
| Title: | Multi-component intervention to determine fit and improve quality of telehealth visits among young adult cancer survivors |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | R21CA21043 |
| Date: | 2022 - 2026 |
| Title: | Evaluating disparities among adolescents and young adults in Texas diagnosed with sarcoma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| ID: | RP220013 |
| Date: | 2021 - 2025 |
| Title: | Trajectories of Adjustment in Young Adult Cancer Patient-Caregiver Dyads: A Measurement Burst Study to Examine Short- and Long-Term Change and Variability |
| Funding Source: | Department of Defense (DOD) |
| Role: | Mentor |
| ID: | CA200949 Career Development Award (W81XWH2110184 ) |
| Date: | 2021 - 2026 |
| Title: | Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 2U01CA199221-07 |
| Date: | 2021 - 2026 |
| Title: | Writing to Heal: Therapeutic Writing to Improve Quality of Life and Reduce Morbidity among Ethnically Diverse Young Adult Breast Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R01CA261868-01 |
| Date: | 2021 - 2022 |
| Title: | Evaluating the role of financial navigation in alleviating financial distress among young adult survivors of blood cancer |
| Funding Source: | Leukemia and Lymphoma Society |
| Role: | Site Principal Investigator |
| Date: | 2021 - 2023 |
| Title: | Development of the MD Anderson Adolescent and Young Adult Cancer Survivorship Study |
| Funding Source: | MDACC Institutional Research Grant |
| Role: | PI |
| Date: | 2020 - 2025 |
| Title: | A Phase I/II study of Bosutinib in pediatric patients with newly diagnosed chronic phase or resistant/intolerant Ph+ chornic myeloid leukemia |
| Funding Source: | Children's Oncology Group/ITCC/Pfizer |
| Role: | AAML1921 Study Vice Chair |
| ID: | AAML1921 |
| Date: | 2020 - 2025 |
| Title: | Symptom Screening Linked to Care Pathways for Children with Cancer: A Cluster Randomized Trial |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | R01CA251112 |
| Date: | 2020 - 2024 |
| Title: | Doxorubicin-induced cardiotoxicity: Defining Blood and echocardiogram biomarkers in a mouse model and AYA sarcoma patients for evaluating exercise interventions |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| ID: | RP200381 |
| Date: | 2019 - 2029 |
| Title: | Increasing AYA clinical trial development and enrollment in the NCI Clinical Trials Network |
| Funding Source: | Children's Oncology Group |
| Role: | Committee Chair |
| ID: | U10CA180886 |
| Date: | 2018 - 2019 |
| Title: | Understanding barriers to AYA clinical trial enrollment at NCORP sites |
| Funding Source: | NCI Community Oncology Research Program |
| Role: | PI |
| Date: | 2018 - 2020 |
| Title: | Molecular Mechanisms of anthracycline response in cardiomyocytes and link to genetic susceptibility to cardiotoxicity in long-term survivors of childhood cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP180166 |
| Date: | 2016 - 2017 |
| Title: | National Pediatric Cancer Foundation Grant |
| Funding Source: | National Pediatric Cancer Foundation |
| Role: | Co-I |
| Date: | 2016 - 2017 |
| Title: | Eisai Research Grant |
| Funding Source: | Eisai |
| Role: | CO-I |
| Date: | 2016 - 2017 |
| Title: | NIH LRP: Pediatric-Extramural Renewal |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Date: | 2015 - 2016 |
| Title: | Adolescent and Young Adult Committee Young Investigator Support |
| Funding Source: | Children's Oncology Group |
| Role: | PI |
| ID: | AYA WO:FP00019337_SUB05_01 |
| Date: | 2014 - 2015 |
| Title: | ICTR Catalytic Seed Grant |
| Funding Source: | Albert Einstein College of Medicine |
| Role: | Investigator |
| ID: | ICTR Catalytic Seed Grant |
| Date: | 2014 - 2016 |
| Title: | NIH LRP: Pediatric-Extramural |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| Date: | 2013 - 2016 |
| Title: | Paul Calabresi Career Development Award for Clinical Oncology |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | K12 CA-132783-04 |
| Date: | 2013 - 2014 |
| Title: | Adolescent and Young Adult Committee Young Investigator Support |
| Funding Source: | Children's Oncology Group |
| Role: | Investigator |
| ID: | AYA WO:FP00016518_SUB12_01 |
| Title: | The AYA Oncology Self-care Movement (#AYAOSM): An Influencer-driven Social Media Intervention for Oral Chemotherapy Adherence |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | PAR-22-164 |
| Title: | Investigating the feasibility of a novel exercise and energy conservation intervention for fatigued young adult brain tumor survivors |
| Funding Source: | NIH |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Haisraely, O, Vedala, S, Al-Sharfeen, A, Manzar, G, Perni, S, Tom, MC, Beckham, TH, Wang, C, Yeboa, DN, Chung, C, McAleer, MF, Ghia, AJ, Ene, CI, Weathers, S, McGovern, SL, Wogan, CF, Roth, M, Li, J, De, BS. Glioblastoma in young adult patients. Journal of neuro-oncology 175(1):323-331, 2025. e-Pub 2025. PMID: 40663309.
- Moore, R, Ahmad, N, Kadosh, M, Daniels, R, Andersen, C, Roth, M, Nelson, KC. Identifying gaps and needs in care for adolescents and young adults with melanoma. Supportive Care in Cancer 33(10), 2025. e-Pub 2025. PMID: 41057735.
- Moore, R, Ahmad, N, Kadosh, M, Daniels, R, Andersen, C, Roth, M, Nelson, KC. Identifying gaps and needs in care for adolescents and young adults with melanoma. Supportive Care in Cancer 33(10), 2025. e-Pub 2025. PMID: 41057735.
- Corrigan, KL, Berkman, AM, Gunther, J, Andersen, C, Wu, SY, Gibson, A, Cuglievan, B, Garcia, MB, Manzar, G, Fang, PQ, De, BS, Ahmed, S, Nunez, CA, Hildebrandt, MA, McCall, DC, Parsons, SK, Roth, M. Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiology Biomarkers and Prevention 34(9):1483-1491, 2025. e-Pub 2025. PMID: 40488452.
- Catueno, S, Ramakrishnan, R, Elitzur, S, Garcia, MB, McCall, DC, Nunez, CA, Roth, M, Ferrajoli, A, Cuglievan, B, Gibson, A. Lymphoid Malignancies in Ataxia–Telangiectasia. Pediatric Blood and Cancer 72(9), 2025. e-Pub 2025. PMID: 40605148.
- Shin-Cho, LJ, Dawkins-Moultin, L, Choi, E, Chen, M, Barcenas, CH, Roth, M, Li, Y, Lu, Q. Feasibility Trial of an Online Expressive Writing Intervention for Young Adult Cancer Survivors. Journal of adolescent and young adult oncology 14(4):328-336, 2025. e-Pub 2025. PMID: 39466058.
- Berkman, AM, Andersen, C, Puthenpura, V, Short, NJ, Merriman, K, Swaminathan, M, Cuglievan, B, McCall, DC, DiNardo, C, Nunez, CA, Jain, N, Kadia, TM, Issa, GC, Gibson, A, Garcia, MB, Andrew Livingston, J, Parsons, SK, Hildebrandt, MA, Roth, M. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectrum 9(4), 2025. e-Pub 2025. PMID: 40579211.
- He, J, Munir, F, Ayerbe, C, Dickson, S, Catueno, S, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Tewari, P, Garcia, MB, Rodriguez, NI, Cortes, JA. Managing and Preventing Hypofibrinogenemia in Pediatric and AYA Leukemia Patients. Journal of Pediatric Hematology/Oncology 47(5):235-241, 2025. e-Pub 2025. PMID: 40306291.
- Beauchemin, M, Murphy-Banks, R, Rodday, AM, Freyer, DR, Miller, KA, Fleisher, E, Ohlsen, TJ, Linendoll, N, Chan, R, Crosswell, HE, Roth, M, Parsons, SK. Factors influencing engagement in survivorship care among young adult survivors of hematologic malignancies. Supportive Care in Cancer 33(7), 2025. e-Pub 2025. PMID: 40562962.
- Dupuis, LL, Vettese, E, Aftandilian, C, Agarwal, V, Baggott, C, Bradfield, SM, Crellin-Parsons, N, Freyer, DR, Kelly, KM, King, AA, Kyono, W, Nagasubramanian, R, Orgel, E, Roth, M, Sherani, F, Yu, L, Grimes, AC, Beauchemin, M, Klesges, LM, Tomlinson, G, Sung, L. Factors Associated With Self-Report Symptom Screening Adherence in Pediatric Cancer Patients. Cancer medicine 14(14), 2025. e-Pub 2025. PMID: 40686265.
- Acquati, C, Cotter-Mena, K, Sanchez, C, LaMarca-Lyon, A, Zhang, A, Roth, M. Informing Psychosocial Care for Young Couples Coping with Early-Onset Breast Cancer. Journal of adolescent and young adult oncology 14(3):227-237, 2025. e-Pub 2025. PMID: 39452509.
- Parsons SK, Montgomery K, Brackett J, Devine K, Embry L, Greenzang K, Lupo P, Nuno M, Rosenberg A, Roth ME, Zupanec S, Hind P. Defining and measuring tolerability in pediatric, adolescent, and young adult oncology: The essential voices. Cancer. e-Pub 2025.
- Siegel D, Schussler N, Alonzo T, Adams S, Angelaszek D, Basavappa S, Chambers T, Coyle L, Durbin E, Goderre J, Hayes T, Howe W, Hsu E, Lee R, Lewis D, Mariotto A, Pollock B, Preda A, Roth ME, Stevens J, Terranova T, Vargas S, Hawkins D, Penberthy L, Lupo P. Enrollment in Children’s Oncology Group’s Clinical Trials: Population-Based Linkage with the National Childhood Cancer Registry. JNCI. e-Pub 2025.
- Crellin-Parsons N, Dupuis LL, Vettese E, Aftandilian C, Agarwal V, Baggott C, Bradfield SM, Freyer DR, Kelly KM, King AA, Kyono W, Nagasubramanian R, Orgel E, Roth ME, Sherani F, Yu L, Grimes AC, Beauchemin MP, Klesges LM, Tomlinson GA, Sung L. Care Pathway- and Guideline-Consistent Care in Pediatric Cancer Symptom Management. JCO Oncol Pract:OP2400912, 2025. e-Pub 2025. PMID: 40267372.
- Zheng D, Murphy-Banks R, Mae Rodday A, Xiang Q, Linendoll N, Beauchemin M, Ohlsen T, Fleisher E, Miller KA, Freyer DR, Croswell H, Chan R, Roth ME, Parsons SK. Nothing is as great a learning experience as getting a $15,000 bill”: a mixed methods study of young adult cancer survivors’ experience with insurance coverage. JCO Oncology Practice. e-Pub 2025.
- Wolfson JA, Grimes AC, Nuno MM, Ramakrishnan S, Dickens DS, Roth ME, Woods W, Adams KS, Alabi T, Beauchemin M, Levine JM, Scialla M, Boayue KB, Kerber CL, Ponce O, Vargas S, Chang GJ, Stock W, Hershman D, Curran E, Advani A, O'Dwyer K, Luger S, Liu JJ, Freyer DR, Sung L, Parsons SK. Guideline-concordant treatment among adolescents and young adults with acute lymphoblastic leukemia. JNCI Cancer Spectr 9(3), 2025. e-Pub 2025. PMID: 40238217.
- Canzona, MR, Victorson, DE, Murphy, KM, Clayman, ML, Reeve, BB, Patel, B, Strahley, AE, McLean, TW, Harry, O, Roth, M, Smith, R, Salsman, JM. Designing Patient-Reported Measures of Fertility. Journal of adolescent and young adult oncology 14(2):180-186, 2025. e-Pub 2025. PMID: 39162473.
- Pereira, LM, Moore, JB, Strahley, AE, Duckworth, K, Ip, EH, Fingeret, MC, Sanford, SD, Canzona, MR, Victorson, DE, Reeve, BB, Roth, M, Smith, R, Salsman, JM. Designing a Measure of Body Image. Journal of adolescent and young adult oncology 14(2):187-193, 2025. e-Pub 2025. PMID: 39535857.
- Belsky, JA, Dupuis, LL, Sung, L, Carter, A, Leisinger, A, Orgel, E, Parsons, SK, Roth, M. Practice patterns in the diagnosis and management of chemotherapy-induced peripheral neuropathy in adolescents and young adults with cancer. Supportive Care in Cancer 33(4), 2025. e-Pub 2025. PMID: 40183879.
- Greenzang KA, Montgomery KE, DuVall A, Roth ME, Krailo M, Nuno MM, Renfro L, DelRocco N, Doski J, Kelly K, Castellino SM, McNeer J, O'Brien MM, Reed D, Janeway K, Hinds PS, Zupanec S, Parsons SK. Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination. J Natl Cancer Inst, 2025. e-Pub 2025. PMID: 40163691.
- Sheikh, IN, Uwaezuoke, D, Okeleji, O, Quesada, AE, Herzog, CE, Ragoonanan, D, Tewari, P, Petropoulos, D, McCall, DC, Nunez, CA, Roth, M, Cuglievan, B, Khazal, SJ. Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. Pediatric Blood and Cancer 72(3), 2025. e-Pub 2025. PMID: 39702892.
- Williams AM, Roth ME. Life after cancer matters: supporting 2.1 million survivors of adolescent and young adult cancer. J Natl Cancer Inst 117(3):385-387, 2025. e-Pub 2025. PMID: 39673288.
- Bleyer, A, Tai, E, Siegel, SE, Roth, M, DeAngelo, DJ, Stock, W. Abatement of the Survival Cliff in Older Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma in the United States. Journal of adolescent and young adult oncology 14(1):33-42, 2025. e-Pub 2025. PMID: 39321033.
- Salsman, JM, Murphy, KM, Addington, EL, Tooze, JA, McLouth, LE, Yang, D, Sanford, SD, Wagner, LI, Bunch, SC, Rosenberg, AR, Valle, CG, Zebrack, BJ, Howard, DS, Roth, M, Moskowitz, JT. Optimization of a digital health intervention to enhance well-being among adolescent and young adult cancer survivors. Contemporary Clinical Trials 149, 2025. e-Pub 2025. PMID: 39710338.
- Roth, M, Andersen, C, Berkman, AM, Siegel, SE, Cuglievan, B, Livingston, JA, Hildebrandt, MA, Estrada, J, Bleyer, A. Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion. Cancer 131(1), 2025. e-Pub 2025. PMID: 39370757.
- Okeleji O, McCall D, Gibson A, Garcia M, Nunez C, Roth ME, Connors J, Petropoulos D, Tewari P, Cuglievan B, Sheikh I. Post-transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2ra acute leukemia. Blood Advances. e-Pub 2025.
- Crelin-Parsons N, Dupuis L, Vettese E, Aftandilian C, Agarwal V, Baggott C, Bradfield S, Freyer D, Kelly K, King A, Kyono W, Orgel E, Roth ME, Sherani F, Yu L, Grimes A, Beauchemin M, Klesges L, Tomlinson G, Sung L. Care pathway-consistent symptom management is uncommon in pediatric cancer patients. JCO Oncology Practice. e-Pub 2025.
- Belsky J, Dupuis L, Sung L, Orgel E, Parsons S, Leisinger A, Roth ME. Practice patterns in the diagnosis and management of chemotherapy-induced peripheral neuropathy in adolescents and young adults with cancer: A Survey of Oncologists. Supportive Care in Cancer. e-Pub 2025.
- Robert R, Andersen C, Murphy K, Medina-George S, Scardaville M, Conley S, Farris D, Roth ME, Nguyen V, Frieden L. Screening Young Adult Cancer Patients to Vocational Rehabilitation Services: A Vocational Rehabilitation Readiness Screening Tool. Journal of Occupational Rehabilitation. e-Pub 2025.
- Catueno S, He J, Munir F, Ayerbe C, Dickson S, Cuglievan B, Gibson A, McCall D, Nunez C, Roth ME, Tewari P, Garcia M, Rodriguez N, Cortes J. Managing and Preventing Hypofibrinogenemia in Pediatric and AYA Leukemia Patients. JPHO. e-Pub 2025.
- Mobley EM, Wolfson JA, Levine J, Ji L, Ramakrishnan S, Nightingale CL, Dressler EV, Kittel C, Freyer DR, Sugalski AJ, Prasad PK, Bhutada JS, Murphy K, Kyono W, Roth ME, Parsons SK, Beauchemin MP. Fertility Preservation Services for Adolescents and Young Adults: 2022 NCI Community Oncology Research Program Landscape Assessment. Journal of Clinical Oncology - Oncology Practice. e-Pub 2025.
- Flores DN, Moerdler S, Palmisiano N, Parsons SK, Roth ME, Devine K. Transition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives. JAYAO. e-Pub 2025.
- Wolfson J, Grimes A, Nuno M, Ramakrishnan S, Dickens D, Roth ME, Woods W, Barnett K, Alabi T, Beauchemin M, Levine J, Scialla M, Boayue K, Kerber C, Ponce O, Vargas S, Chang G, Stock W, Hershman D, Curan E, Advani A, O’Dwyer K, Luger S, Liu J, Freyer D, Sung L, Parsons S. Guideline-Concordant Treatment among Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL). JNCI Cancer Spectrum. e-Pub 2025.
- Dupuis, LL, Vettese, E, Grimes, AC, Beauchemin, M, Klesges, LM, Baggott, C, Demedis, J, Aftandilian, C, Freyer, DR, Crellin-Parsons, N, Orgel, E, Dickens, DS, Kelly, KM, Kyono, W, Walsh, A, Sherani, F, Cannone, D, Orsey, AD, King, AA, Yu, L, Woods-Swafford, W, Bradfield, SM, Roth, M, Esbenshade, AJ, Caywood, EH, Agarwal, V, Nagasubramanian, R, Tomlinson, G, Sung, L. Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer. JAMA 332(23):1981-1991, 2024. e-Pub 2024. PMID: 39535768.
- Milam, J, Kim, Y, Roth, M, Freyer, DR. Late effects surveillance adherence among young adult childhood cancer survivors. Pediatric Blood and Cancer 71(12), 2024. e-Pub 2024. PMID: 39289858.
- McCall, DC, Alqahtani, S, Budak, M, Sheikh, IN, Fan, AE, Ramakrishnan, R, Nunez, CA, Roth, M, Garcia, M, Gibson, A, Daver, N, Garces, S, Short, NJ, Issa, GC, Ravandi-Kashani, F, DiNardo, C, Montalban Bravo, G, Garcia-Manero, G, Cuglievan, B, Kadia, TM. Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience. Cancers 16(22), 2024. e-Pub 2024. PMID: 39594839.
- Gibson A, Nunez C, Robusto L, Kammerer B, Garcia M, Roth M, Sheth R, Tewari P, Hittle A, Toepfer L, Torres R, Short NJ, Jabbour E, Jain N, Cuglievan B, McCall D. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica 109(9):3042-3047, 2024. e-Pub 2024. PMID: 38779719.
- Choi E, Berkman AM, Andersen CR, Salsman JM, Betts AC, Milam J, Miller KA, Peterson SK, Lu Q, Cheung CK, Ghazal LV, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Psychological distress and mental health care utilization among lesbian, gay, and bisexual survivors of adolescent and young adult cancer. Support Care Cancer 32(9):585, 2024. e-Pub 2024. PMID: 39134915.
- McCall D, Abuasab T, Rodriguez-Sevilla JJ, Mohamed SF, Patnaik A, Devireddy K, Arani N, Sheikh I, Jamshidi R, Gibson A, Roth M, Nunez C, Garcia M, Chien KS, Loghavi S, Pierce SA, Sasaki K, Issa G, Cuglievan B, Kantarjian H, Garcia-Manero G. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis. Leuk Res 144:107563, 2024. e-Pub 2024. PMID: 39178611.
- Parsons SK, Murphy-Banks R, Rodday AM, Roth ME, Miller K, Linendoll N, Chan R, Crosswell HE, Xiang Q, Freyer DR. Financial Distress and Medical Financial Hardship among Young Adult Survivors of Blood Cancer. JNCI Cancer Spectr 8(5), 2024. e-Pub 2024. PMID: 39153000.
- Gibson A, Dickson S, McCall D, Garcia M, Connors J, He J, Roth M, Nunez C, Cuglievan B. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia. Pediatr Blood Cancer 71(11):e31286, 2024. e-Pub 2024. PMID: 39152634.
- Rodriguez ER, Tonn T, Jafry M, Ahmed S, Cuglievan B, Livingston JA, Flowers CR, Aune GJ, Albritton KH, Roth ME, Xiao Q, Hildebrandt MAT. Neighborhood-level social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival. JNCI Cancer Spectr 8(4), 2024. e-Pub 2024. PMID: 39051679.
- Mollica, M, McWhirter, G, Tonorezos, ES, Fenderson, J, Freyer, DR, Jefford, M, Luevano, CJ, Mullett, TW, Nasso, SF, Schilling, E, Passero, VA, Schwartz, LA, Schmitz, KH, Schatz, AA, Sanft, T, Roth, M, Pergolotti, M, Penedo, FJ, Nekhlyudov, L, Merrill, JK, Mayer, D, Maher, M, Macintyre, J, Kline, R, Kirschner, M, Kirchoff, A, Keating, NL, Jacobs, LA, Hudson, S, Honig, B, He, M, Ganz, PA, Friedman, DN, Francis, L, Cavanagh, H, Blaes, A, Belin, P, Alfano, CM. Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach. Journal of Cancer Survivorship 18(4):1190-1199, 2024. e-Pub 2024. PMID: 38739299.
- Tortolero GA, Betts AC, Suragh TA, Pruitt SL, Roth ME, Murphy CC. Social vulnerability and survival in 112,000 adolescents and young adults with cancer: a population-based study. J Natl Cancer Inst 116(12):2003-2008, 2024. e-Pub 2024. PMID: 39084675.
- Alqahtani S, Ramakrishnan R, E S, Wang SA, Nunez C, McCall D, Garcia MB, Roth ME, Cuglievan B, Gibson A. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer 71(8):e31123, 2024. e-Pub 2024. PMID: 38837565.
- George GC, Andersen C, Tang X, Rodriguez E, Jafry M, Swartz MC, Ahmed S, Barcenas CH, Livingston JA, Roth ME, Hildebrandt MAT. Patient-Reported Quality of Life at Diagnosis in Adolescent and Young Adults With Cancer. J Natl Compr Canc Netw 22(6), 2024. e-Pub 2024. PMID: 38996438.
- Salsman JM, Nightingale CL, Canzona MR, Howard DS, Tucker-Seeley RD, Wiseman KD, Victorson DE, Robles JM, Roth M, Smith R, Reeve BB, Danhauer SC. Asking the "Right" Questions about Financial Hardship: Using Cognitive Interviews with Adolescents and Young Adults with Cancer and Their Caregivers to Inform Measure Development. J Adolesc Young Adult Oncol 13(5):760-767, 2024. e-Pub 2024. PMID: 38959182.
- Stafford LK, Tang X, Brandt A, Ma J, Banchs J, Livingston JA, Roth ME, Morrison AC, Hildebrandt MAT. Risk of anthracycline-induced cardiac dysfunction in adolescent and young adult (AYA) cancer survivors: role of genetic susceptibility loci. Pharmacogenomics J 24(4):21, 2024. e-Pub 2024. PMID: 38951505.
- Berkman AM, Andersen CR, Landstrom AP, Hildebrandt MAT, Gilchrist SC, Roth ME. Cardiovascular Disease in Childhood, Adolescent, and Young Adult Cancer Survivors: The Impact of Family History of Premature Heart Disease. J Adolesc Young Adult Oncol 13(3):548-556, 2024. e-Pub 2024. PMID: 38261412.
- Beauchemin MP, Ji L, Williams AM, Nightingale CL, Dressler EV, Salsman JM, Santacroce SJ, Freyer DR, Roth ME, Parsons SK. Defining Practice Capacity for Cancer Care Delivery to Adolescents and Young Adults in the Community Setting: 2022 Landscape Assessment Results. J Adolesc Young Adult Oncol 13(3):557-563, 2024. e-Pub 2024. PMID: 38394227.
- Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, Roth M, Ragoonanan D, Connors J, Herzog CE, Cuglievan B, Garcia MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatr Blood Cancer 71(6):e30964, 2024. e-Pub 2024. PMID: 38514796.
- Psihogios AM, Roth M, Gomez C, Hekimian-Brogan E, McQueen C, Yanez B. Partnering With Social Media Influencers to Equitably Improve Adolescent and Young Adult Cancer Outcomes: A Novel Strategy to Support Cancer Care Delivery. JCO Oncol Pract 20(6):755-760, 2024. e-Pub 2024. PMID: 38408282.
- Betts AC, Roth ME, Albritton K, Pruitt SL, Lupo PJ, Wang JS, Shay LA, Allicock MA, Murphy CC. Racialized inequities in live birth after cancer: A population-based study of 63,000 female adolescents and young adults with cancer. Cancer 130(17):2928-2937, 2024. e-Pub 2024. PMID: 38696087.
- Siegel DA, Durbin EB, Pollock BH, Grimes A, Ji L, Alonzo TA, Vargas SL, Huang B, McDowell JR, Lycan E, Ransdell P, Tai E, Roth ME, Freyer DR. Population-Based Data Linkage Describing Patterns of Cancer Clinical Trial Enrollment Among Children and Adolescents. JCO Oncol Pract 20(5):631-642, 2024. e-Pub 2024. PMID: 38194612.
- Choi E, Berkman AM, Battle A, Betts AC, Salsman JM, Milam J, Andersen CR, Miller KA, Peterson SK, Lu Q, Cheung CK, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Psychological distress and mental health care utilization among Black survivors of adolescent and young adult cancer. Cancer 130(17):3011-3022, 2024. e-Pub 2024. PMID: 38676935.
- Cho D, Roth M, Peterson SK, Jennings K, Kim S, Weathers SP, Ahmed S, Livingston JA, Barcenas C, You YN, Milbury K. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study. JMIR Res Protoc 13(1):e53307, 2024. e-Pub 2024. PMID: 38652520.
- Wolfson JA, Grimes AC, Nuno M, Kerber CL, Ramakrishnan S, Beauchemin M, Dickens D, Levine JM, Roth ME, Scialla M, Woods W, Vargas S, Boayue KB, Chang GJ, Stock W, Hershman D, Curran E, Advani A, O'Dwyer K, Luger S, Liu JJ, Freyer DR, Sung L, Parsons SK. Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL. JCO Oncol Pract 20(4):491-502, 2024. e-Pub 2024. PMID: 38252911.
- George IA, Souder B, Berkman A, Noyd DH, Jay Campbell M, Barker PCA, Roth M, Hildebrandt MAT, Oeffinger KC, McCrary AW, Landstrom AP. Obesity Predisposes Anthracycline-Treated Survivors of Childhood and Adolescent Cancers to Subclinical Cardiac Dysfunction. Pediatr Cardiol 46(2):362-371, 2024. e-Pub 2024. PMID: 38456890.
- Brivio E, Pennesi E, Willemse ME, Huitema ADR, Jiang Y, van Tinteren HDR, van der Velden VHJ, Beverloo BH, den Boer ML, Rammeloo LAJ, Hudson C, Heerema N, Kowalski K, Zhao H, Kuttschreuter L, Bautista Sirvent FJ, Bukowinski A, Rizzari C, Pollard J, Murillo-Sanjuan L, Kutny M, Zarnegar-Lumley S, Redell M, Cooper S, Bertrand Y, Petit A, Krystal J, Metzler M, Lancaster D, Bourquin JP, Motwani J, van der Sluis IM, Locatelli F, Roth ME, Hijiya N, Zwaan CM. Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. J Clin Oncol 42(7):821-831, 2024. e-Pub 2024. PMID: 38033284.
- Cheung CK, Miller KA, Goings TC, Thomas BN, Lee H, Brandon RE, Katerere-Virima T, Helbling LE, Causadias JM, Roth ME, Berthaud FM, Jones LP, Ross VA, Betz GD, Simmons CD, Carter J, Davies SJ, Gilman ML, Lewis MA, Lopes G, Tucker-Seeley RD. BIPOC experiences of (anti-)racist patient engagement in adolescent and young adult oncology research: an electronic Delphi study. Future Oncol 20(9):547-561, 2024. e-Pub 2024. PMID: 38197386.
- Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Risk of chronic health conditions in lesbian, gay, and bisexual survivors of adolescent and young adult cancers. Cancer 130(4):553-562, 2024. e-Pub 2024. PMID: 38044705.
- Wooten, SV, Amini, B, Roth, M, Leung, CH, Wang, J, Hildebrandt, MA, Kleinerman, ES. Adolescent and young adult Hodgkin lymphoma patients at risk for subcutaneous fat gain during early cancer treatment. Leukemia and Lymphoma 65(1):62-68, 2024. e-Pub 2024. PMID: 37878765.
- McCall D, Alqhatani S, Budak M, Sheikh I, Fan A, Ramakrishnan R, Nunez C, Roth ME, Garcia M, Gibson A, Daver N, Garces S, Short N, Issa G, Ravandi F, DiNardo C, Montalban Bravo G, Garcia-Manero G, Cuglievan B, Kadia T. Cladribine-Based Therapy for Relapsed or Refractory Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience. Cancer. e-Pub 2024.
- Roth ME, Merrill J, Henderson T. CC-Connect: Identifying solutions to elevating the cancer experience for adolescents and young adults (AYA) with cancer. JNCI. e-Pub 2024.
- Milam J, Kim Y, Roth M, Freyer D. Late Effects Surveillance Adherence Among Under-Represented Young Adult Childhood Cancer Survivors: A Population-based Study. Pediatric Blood and Cancer. e-Pub 2024.
- Shin-Cho L, Dawkin-Moulton L, Choi E, Chen M, Barcenas C, Roth ME, Li Y, Lu Q. Feasibility Trial of an Online Expressive Writing Intervention for Young Adult Cancer Survivors. JAYAO. e-Pub 2024.
- Choi, E, Berkman, AM, Cheung, CK, Betts, AC, Salsman, JM, Andersen, C, Ochoa-Dominguez, CY, Miller, KA, Milam, J, Shah, A, Peterson, SK, Lu, Q, Livingston, JA, Hildebrandt, MA, Parsons, SK, Freyer, DR, Roth, M. Psychological distress and mental health care utilization among Hispanic/Latino survivors of adolescent and young adult cancer. Psycho-oncology 32(12):1918-1929, 2023. e-Pub 2023. PMID: 37955581.
- Cole Wyant, Kyle Fitzgerald, Yimin Geng, Michael Roth. Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials. JCO Oncol Pract 19(11):1048-1052, 2023. e-Pub 2023. PMID: 37748116.
- Jeyabal P, Bhagat A, Wang F, Roth M, Livingston JA, Gilchrist SC, Banchs J, Hildebrandt MAT, Chandra J, Deswal A, Koutroumpakis E, Wang J, Daw NC, Honey TA, Kleinerman ES. Circulating microRNAs and cytokines as prognostic biomarkers for doxorubicin-induced cardiac injury and for evaluating the effectiveness of an exercise intervention. Clin Cancer Res 29(21):4430-4440, 2023. e-Pub 2023. PMID: 37651264.
- Wooten, SV, Wang, F, Roth, M, Liu, G, Livingston, JA, Amini, B, Gilchrist, SC, Hildebrandt, MA, Kleinerman, ES. Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy. Cancer medicine 12(22):20798-20809, 2023. e-Pub 2023. PMID: 37902220.
- Parsons SK, Beauchemin MP, Dupuis L, Sugalski A, Wolfson JA, Santacroce SJ, Marchak JG, Sung L, Roth ME, COG Cancer Care Delivery Research Committee COG. Children's Oncology Group 2023 blueprint for research: Cancer care delivery research. Pediatr Blood Cancer 70 Suppl 6(S6):e30579, 2023. e-Pub 2023. PMID: 37469004.
- Roth ME, Grimes AC, Reed DR, Weiss AR, Mittal N, Parsons SK, Freyer DR, COG Adolescent and Young Adult Oncology Discipline Committee COG. Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology. Pediatr Blood Cancer 70 Suppl 6(S6):e30564, 2023. e-Pub 2023. PMID: 37439574.
- Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Parsons SK, Roth M. Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer. JCO Oncol Pract 19(8):OP2200852, 2023. e-Pub 2023. PMID: 37311165.
- Spencer K, Pappas L, Baiev I, Maurer J, Bocobo AG, Zhang K, Jain A, De Armas AD, Reyes S, Le TM, Rahma OE, Stanton J, DeLeon TT, Roth M, Peters MLB, Zhu AX, Lennerz JK, Iafrate AJ, Boyhen K, VanCott C, Roberts LR, Lindsey S, Horick N, Goff LW, Mody K, Borad MJ, Shroff RT, Kelley RK, Javle MM, Goyal L. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. J Natl Cancer Inst 115(7):870-880, 2023. e-Pub 2023. PMID: 37040087.
- Cheung CK, Lee H, Levin NJ, Choi E, Ross VA, Geng Y, Thomas BN, Roth ME. Disparities in cancer care among sexual and gender minority adolescent and young adult patients: A scoping review. Cancer Med 12(13):14674-14693, 2023. e-Pub 2023. PMID: 37245227.
- Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Roth M. Patient-reported quality of life in adolescents and young adults with cancer who received radiation therapy. Cancer Med 12(13):14157-14170, 2023. e-Pub 2023. PMID: 37199075.
- Beauchemin MP, Roth ME, Parsons SK. Response to Barr re: "Reducing Adolescent and Young Adult Cancer Outcome Disparities Through Optimized Care Delivery: A Blueprint from the Children's Oncology Group". J Adolesc Young Adult Oncol 12(3):459, 2023. e-Pub 2023. PMID: 37126787.
- Beauchemin MP, Roth ME, Parsons SK. Reducing Adolescent and Young Adult Cancer Outcome Disparities Through Optimized Care Delivery: A Blueprint from the Children's Oncology Group. J Adolesc Young Adult Oncol 12(3):314-323, 2023. e-Pub 2023. PMID: 36716260.
- Berkman AM, Andersen CR, Tang K, Gilchrist SC, Roth ME. Disparities in physical activity in adolescent and young adult cancer survivors. J Cancer Surviv 17(3):848-858, 2023. e-Pub 2023. PMID: 36350484.
- Betts AC, Shay LA, Lupo PJ, Pruitt SL, Roth ME, Allicock MA, Cohn BA, Murphy CC. Adverse birth outcomes of adolescent and young adult women diagnosed with cancer during pregnancy. J Natl Cancer Inst 115(6):619-627, 2023. e-Pub 2023. PMID: 36912709.
- Rav ES, Wahba A, Patnaik A, Toruner G, Hittle A, Toepfer L, Roth M, Cuglievan B, Nunez C, McCall D. A balancing act: Blinatumomab use in a rare occurrence of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in an adolescent patient with Down syndrome. Pediatr Blood Cancer 70(5):e30191, 2023. e-Pub 2023. PMID: 36602024.
- Puthenpura V, Ji L, Xu X, Roth ME, Freyer DR, Frazier AL, Marks AM, Pashankar FD. Loss to follow-up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group. Cancer 129(10):1547-1556, 2023. e-Pub 2023. PMID: 36813754.
- Vettese E, Sherani F, King AA, Yu L, Aftandilian C, Baggott C, Agarwal V, Nagasubramanian R, Kelly KM, Freyer DR, Orgel E, Bradfield SM, Kyono W, Roth M, Klesges LM, Beauchemin M, Grimes A, Tomlinson G, Dupuis LL, Sung L. Symptom management care pathway adaptation process and specific adaptation decisions. BMC Cancer 23(1):350, 2023. e-Pub 2023. PMID: 37069510.
- Berkman AM, Andersen CR, Hildebrandt MAT, Livingston JA, Green AL, Puthenpura V, Peterson SK, Milam J, Miller KA, Freyer DR, Roth ME. Risk of early death in adolescents and young adults with cancer: a population-based study. J Natl Cancer Inst 115(4):447-455, 2023. e-Pub 2023. PMID: 36682385.
- Acquati C, Wittmann D, Roth M, Rosen A, Carr LC, Gresham Z, Ionescu E. Sexual Health Outcomes of Adolescent and Young Adult Colorectal Cancer Survivors and Their Partners: Protocol of a Dyadic Mixed Methods Study. JMIR Res Protoc 12:e41831, 2023. e-Pub 2023. PMID: 36951909.
- Trabal A, Gibson A, He J, McCall D, Roth M, Nuñez C, Garcia M, Buzbee M, Toepfer L, Bidikian A, Daver N, Kadia T, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garces S, Marcogliese A, Paek H, Dreyer Z, Brackett J, Redell M, Yi J, Garcia-Manero G, Konopleva M, Stevens A, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers (Basel) 15(7), 2023. e-Pub 2023. PMID: 37046645.
- Choi E, Becker H, Lu Q, Roth M. Sex differences in comorbid conditions, health behaviors, health care utilization, and health-related quality of life among young adult cancer survivors. Support Care Cancer 31(3):181, 2023. e-Pub 2023. PMID: 36820926.
- Berkman AM, Andersen CR, Roth ME, Gilchrist SC. Cardiovascular disease in adolescent and young adult cancer survivors: Impact of sociodemographic and modifiable risk factors. Cancer 129(3):450-460, 2023. e-Pub 2023. PMID: 36464957.
- McCall D, Jabbour E, Roth M, Nunez C, Cuglievan B. Mini-hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B-acute lymphoblastic leukemia. Pediatr Blood Cancer 70(1):e29939, 2023. e-Pub 2023. PMID: 36031729.
- Harrison D, Gill J, Roth M, Hingorani P, Zhang W, Teicher B, Earley E, Erickson S, Gatto G, Kurmasheva R, Houghton P, Smith M, Anders Kolb E, Gorlick R. Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma. Pediatr Blood Cancer 70(1):e30017, 2023. e-Pub 2023. PMID: 36250964.
- Roth ME, Parsons SK, Ganz PA, Wagner LI, Hinds PS, Alexander S, Bingen K, Bober SL, Brackett J, Cella D, Henry NL, Indelicato DJ, Johnson RH, Miller TP, Rosenberg SM, Schmitz KH, Thanarajasingam G, Reeve BB, Salsman JM. Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials. J Natl Cancer Inst 115(1):21-28, 2023. e-Pub 2023. PMID: 36266760.
- Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Battle A, Hildebrandt MAT, Parsons SK, Roth ME. Excess risk of chronic health conditions in Black adolescent and young adult cancer survivors. J Cancer Surviv 18(6):1931-1940, 2023. e-Pub 2023. PMID: 37578615.
- Wooten SV, Amini B, Livingston JA, Hildebrandt MAT, Chandra J, Gilchrist SC, Roth M, Kleinerman E. Poor Sit-to-Stand Performance in Adolescent and Young Adult Patients with Sarcoma. J Adolesc Young Adult Oncol 12(6):821-827, 2023. e-Pub 2023. PMID: 37155195.
- Berkman AM, Choi E, Salsman JM, Peterson SK, Cheung CK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Excess risk of chronic health conditions in Hispanic survivors of adolescent and young adult cancers. J Cancer Surviv 18(3):907-916, 2023. e-Pub 2023. PMID: 36750493.
- Betts AC, Murphy CC, Shay LA, Balasubramanian BA, Markham C, Roth ME, Allicock M. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008-2017. J Cancer Surviv 17(6):1688-1697, 2023. e-Pub 2022. PMID: 36346577.
- Canavera KE, Bjornard KL, Cost NG, Grady A, Irving H, Kaye EC, Ketterl T, Levine J, Reinecke J, Rios J, Roth M, Sawyer K, Thomas SM, Unguru Y, Johnson LM. Disparate Access to Fertility Preservation in Youth: A Call for Advocacy to Close the Gap. J Pediatr 261:113496, 2023. e-Pub 2023. PMID: 37211206.
- He J, Garcia MB, Connors JS, Nuñez CA, Quesada AE, Gibson A, Roth M, Cuglievan B, Pemmaraju N, McCall D. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. J Pediatr Hematol Oncol 45(8):E1001-E1004, 2023. e-Pub 2023. PMID: 37661300.
- Terao M, Mittal N, Roth M, Saha A, Super L, Reichek J. Utilization of Teleconsent for Adolescent and Young Adult Cancer Clinical Trials, a Report from the Children's Oncology Group. J Adolesc Young Adult Oncol 13(1):132-137, 2023. e-Pub 2023. PMID: 37540127.
- Moerdler S, DuVall AS, Hayes-Lattin B, Grimes A, Prasad PK, Molina JC, Monga V, Freyer DR, Roth ME. Gaps in Adolescent and Young Adult Cancer Education in Oncology Fellowship Training. J Adolesc Young Adult Oncol 13(1):97-104, 2023. e-Pub 2023. PMID: 37477884.
- Lopez-Olivo MA, James J, James J, Krause KJ, Roth M, Palos GR, Ma H, Rodriguez A, Gilmore K, Cinciripini P, Suarez-Almazor ME. A systematic review and meta-analysis of e-cigarette use among cancer survivors. J Cancer Surviv 18(3):1059-1074, 2023. e-Pub 2023. PMID: 36952212.
- Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Socioeconomic Status and Chronic Health Conditions in Asian Survivors of Adolescent and Young Adult Cancers. J Adolesc Young Adult Oncol 13(2):262-270, 2023. e-Pub 2023. PMID: 37594775.
- Corrigan KL, Roth M. Treatment-Associated Breast Cancer Following Childhood Cancer: Where Do We Go From Here?. JAMA Oncol 8(12):1774-1775, 2022. e-Pub 2022. PMID: 36227620.
- Nightingale CL, Canzona MR, Danhauer SC, Reeve BB, Howard DS, Tucker-Seeley RD, Golden SLS, Little-Greene D, Roth ME, Victorson DE, Salsman JM. Financial burden for caregivers of adolescents and young adults with cancer. Psychooncology 31(8):1354-1364, 2022. e-Pub 2022. PMID: 35416372.
- Smith SM, Zhang S, Sundaram V, Roth M, Andolina JR, Schapira L, Sakamoto KM, Kolb EA, Hijiya N, Chaudhury S. Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. Pediatr Hematol Oncol 39(5):1-15, 2022. e-Pub 2022. PMID: 34918996.
- Hingorani P, Zhang W, Zhang Z, Xu Z, Wang WL, Roth ME, Wang Y, Gill JB, Harrison DJ, Teicher BA, Erickson SW, Gatto G, Kolb EA, Smith MA, Kurmasheva RT, Houghton PJ, Gorlick R. Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, is effective in pediatric solid tumors: A report by the Pediatric Preclinical Testing Consortium. Mol Cancer Ther 21(8):1318-1325, 2022. e-Pub 2022. PMID: 35657346.
- Corrigan KL, Fu S, Chen YS, Kaiser K, Roth M, Peterson SK, Shih YT, Jagsi R, Giordano SH, Volk RJ, Yabroff KR, Banegas MP, Acquati C, Conti RM, Ma HY, Ku K, You YN, Smith GL. Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer 128(13):2455-2462, 2022. e-Pub 2022. PMID: 35417565.
- Wang Y, Tian X, Zhang W, Zhang Z, Lazcano R, Hingorani P, Roth ME, Gill JD, Harrison DJ, Xu Z, Jusu S, Kannan S, Wang J, Lazar AJ, Earley EJ, Erickson SW, Gelb T, Huxley P, Lahdenranta J, Mudd G, Kurmasheva RT, Houghton PJ, Smith MA, Kolb EA, Gorlick R. Comprehensive surfaceome profiling to identify and validate novel cell-surface targets in osteosarcoma. Mol Cancer Ther 21(6):903-913, 2022. e-Pub 2022. PMID: 35312779.
- Morand M, Roth M, Peterson SK, Bednar EM, Ramdaney A, Livingston JA, Yarbrough A, Corredor J. Factors impacting adolescent and young adult cancer patients' decision to pursue genetic counseling and testing. Support Care Cancer 30(6):5481-5489, 2022. e-Pub 2022. PMID: 35306607.
- Berkman AM, Andersen CR, Cuglievan B, McCall DC, Lupo PJ, Parsons SK, DiNardo CD, Short NJ, Jain N, Kadia TM, Livingston JA, Roth ME. Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis. Cancer Epidemiol Biomarkers Prev 31(6):1176-1184, 2022. e-Pub 2022. PMID: 35553621.
- Wooten SV, Roth M, Livingston JA, Hildebrandt MAT, Chandra J, Amini B, Kleinerman ES, Gilchrist SC. Short-Term Changes in Skeletal Muscle Mass After Anthracycline Administration in Adolescent and Young Adult Sarcoma Patients. J Adolesc Young Adult Oncol 11(3):320-322, 2022. e-Pub 2022. PMID: 34388045.
- Siembida EJ, Loomans-Kropp HA, Tami-Maury I, Freyer DR, Sung L, Crosswell HE, Pollock BH, Roth ME. Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics. Oncologist 27(5):363-370, 2022. e-Pub 2022. PMID: 35522559.
- Avutu V, Monga V, Mittal N, Saha A, Andolina JR, Bell DE, Fair DB, Flerlage JE, Frediani JN, Heath JL, Kahn JM, Reichek JL, Super L, Terao MA, Freyer DR, Roth ME. Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncol Pract 18(3):OP2100554, 2022. e-Pub 2022. PMID: 34905405.
- Mittal N, Saha A, Avutu V, Monga V, Freyer DR, M||n R. Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials. Sci Rep 12(1):3875, 2022. e-Pub 2022. PMID: 35264642.
- Moerdler S, Steinberg DM, Jin Z, Cole PD, Kesselheim J, Levy AS, Roth M, Rosenthal SL. Provider and staff crisis well-being associated with trust in leadership and baseline burnout. Pediatr Blood Cancer 69(3):e29497, 2022. e-Pub 2022. PMID: 34890105.
- Berkman AM, Robert RS, Roth M, Askins MA. A review of psychological symptoms and post-traumatic growth among adolescent and young adult survivors of childhood cancer. J Health Psychol 27(4):1359105320971706, 2022. e-Pub 2022. PMID: 33153307.
- Sheikh I, Nunez C, McCall D, Roth M, Cuglievan B. Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient. Pediatr Blood Cancer 69(3):e29390, 2022. e-Pub 2022. PMID: 35077016.
- Andolina JR, Wang YC, Ji L, Freyer DR, Levine JE, Pulsipher MA, Gamis AS, Aplenc R, Roth ME, Harrison L, Cairo MS. Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience. Bone Marrow Transplant 57(3):445-452, 2022. e-Pub 2022. PMID: 34992254.
- Roth, M, Berkman, AM, Andersen, C, Cuglievan, B, Livingston, JA, Hildebrandt, MA, Bleyer, A. Improved Survival of Young Adults with Cancer Following the Passage of the Affordable Care Act. Oncologist 27(2):135-143, 2022. e-Pub 2022. PMID: 35641206.
- Zhang A, Zebrack B, Acquati C, Roth M, Levin NJ, Wang K, Schwartz S. Technology-assisted psychosocial interventions for childhood, adolescent,and young adult cancer survivors: A systematic review and meta-analysis. J Adolesc Young Adult Oncol 11(1):6-16, 2022. e-Pub 2022. PMID: 33960845.
- Mittal N, Langevin AM, Kyono W, Dickens DS, Grimes A, Salsman JM, Pollock BH, Roth M. Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial. J Adolesc Young Adult Oncol 11(1):117-121, 2022. e-Pub 2022. PMID: 33983848.
- Gibson, A, Trabal, AM, McCall, DC, Khazal, SJ, Toepfer, L, Bell, D, Roth, M, Mahadeo, KM, Nunez, CA, Short, NJ, DiNardo, C, Konopleva, M, Issa, GC, Ravandi-Kashani, F, Jain, N, Borthakur, G, Kantarjian, HM, Jabbour, EJ, Cuglievan, B. Venetoclax for children and adolescents with acute lymphoblastic leukemia and lymphoblastic lymphoma. Cancers 14(1), 2022. e-Pub 2022. PMID: 35008312.
- Hesko C, Mittal N, Avutu V, Thomas SM, Heath JL, Roth ME. Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative). Curr Probl Cancer 47(6):100898, 2022. e-Pub 2022. PMID: 36207194.
- McCall D, Roth M, Mahadeo KM, Toepfer L, Nunez C, Short NJ, Daver N, Kadia TM, DiNardo C, Yi JS, Cuglievan B. Gilteritinib Combination Therapies in Pediatric Patients with FLT3 Mutated Acute Myeloid Leukemia. Blood Adv 5(23):5215-5219, 2021. e-Pub 2021. PMID: 34592761.
- Berkman AM, Murphy KM, Siembida EJ, Lau N, Geng Y, Parsons SK, Salsman JM, Roth ME. Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov. Value Health 24(12):1820-1827, 2021. e-Pub 2021. PMID: 34838280.
- Berkman AM, Andersen CR, Puthenpura V, Livingston JA, Ahmed S, Cuglievan B, Hildebrandt MAT, Roth ME. Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors. Cancer Epidemiol 75:102044, 2021. e-Pub 2021. PMID: 34597882.
- Roth M, Beauchemin M, Kahn JM, Bleyer A. Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults. Cancer Med 10(21):7620-7628, 2021. e-Pub 2021. PMID: 34592782.
- Kurmasheva RT, Erickson SW, Han R, Teicher BA, Smith MA, Roth M, Gorlick R, Houghton PJ. In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC). Pediatr Blood Cancer 68(11):e29304, 2021. e-Pub 2021. PMID: 34453478.
- Baig MU, Rytting M, Roth M, Morani AC, Nunez C, Lin P, Cuglievan B. Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma. J Pediatr Hematol Oncol 43(7):e991-e996, 2021. e-Pub 2021. PMID: 33480649.
- Berkman AM, Andersen CR, Puthenpura V, Livingston JA, Ahmed S, Cuglievan B, Hildebrandt MAT, Roth ME. Impact of race, ethnicity and socioeconomic status over time on the long-term survival of adolescent and young adult Hodgkin lymphoma survivors. Cancer Epidemiol Biomarkers Prev 30(9):1717-1725, 2021. e-Pub 2021. PMID: 34244160.
- Murphy CC, Lupo PJ, Roth ME, Winick NJ, Pruitt SL. Disparities in cancer survival among adolescents and young adults: a population-based study of 88,000 patients. J Natl Cancer Inst 113(8):1074-1083, 2021. e-Pub 2021. PMID: 33484568.
- Bishop AJ, Livingston JA, Ning MS, Valdez ID, Wages CA, McAleer MF, Paulino AC, Grosshans DR, Woodhouse KD, Tao R, Roth ME, Gunn GB, McGovern SL. Young Adult Populations Face yet another Barrier to Care with Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys 110(5):1496-1504, 2021. e-Pub 2021. PMID: 33677051.
- Puthenpura, V, Canavan, ME, Poynter, JN, Roth, M, Pashankar, F, Jones, BA, Marks, AM. Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors. Pediatric Blood and Cancer 68(7), 2021. e-Pub 2021. PMID: 33704901.
- Makhnoon S, Corredor J, Arun B, Bell D, Yarbrough A, Livingston JA, Peterson SK, Roth M. Impact of a Genetic Evaluation Initiative to Increase Access to Genetic Services for Adolescent and Young Adults at a Tertiary Cancer Hospital. J Adolesc Young Adult Oncol 10(3):296-302, 2021. e-Pub 2021. PMID: 32830989.
- Siembida EJ, Loomans-Kropp HA, Tami-Maury I, Freyer DR, Sung L, Crosswell HE, Pollock BH, Roth ME. Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives. JNCI Cancer Spectr 5(3):pkab027, 2021. e-Pub 2021. PMID: 34104866.
- Cuglievan B, Berkman A, Dibaj S, Wang J, Andersen CR, Livingston JA, Gill J, Bleyer A, Roth M. Impact of Lagtime, Health Insurance Type, and Income Status at Diagnosis on the Long-Term Survival of Adolescent and Young Adult Cancer Patients. J Adolesc Young Adult Oncol 10(2):164-174, 2021. e-Pub 2021. PMID: 32678703.
- Hingorani P, Roth ME, Wang Y, Zhang W, Gill JD, Harrison DJ, Teicher B, Erickson S, Gatto G, Smith MA, Kolb EA, Gorlick R. ABBV-085, antibody-drug conjugate targeting LRRC15, is effective in osteosarcoma: A report by the Pediatric Preclinical Testing Consortium. Mol Cancer Ther 20(3):535-540, 2021. e-Pub 2020. PMID: 33298592.
- Zvi Y, Ugur E, Batko B, Gill J, Roth M, Gorlick R, Hall D, Tingling J, Barkauskas DA, Zhang J, Yang R, Hoang BH, Geller DS. Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma. Sarcoma 2021:8324348, 2021. e-Pub 2021. PMID: 33603563.
- Kacew AJ, Grimes AC, Roth M, Teoh D, Landier W, Strohbehn GW, Paskett ED. The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers. CA Cancer J Clin 70(6):518-519, 2020. e-Pub 2020. PMID: 33063840.
- Gill J, Zhang W, Zhang Z, Roth M, Harrison DJ, Rowshan S, Erickson S, Gatto G, Kurmasheva R, Houghton P, Teicher B, Smith MA, Kolb EA, Gorlick R. Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium. Pediatr Blood Cancer 67(10):e28606, 2020. e-Pub 2020. PMID: 32706456.
- Dickens DS, Roth ME, Pollock BH, Langevin AM. Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs. JCO Oncol Pract 16(10):JOP1900707, 2020. e-Pub 2020. PMID: 32396490.
- Roth M, Mittal N, Saha A, Freyer DR. The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment. J Adolesc Young Adult Oncol 9(4):522-527, 2020. e-Pub 2020. PMID: 32077782.
- Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka D, DePombo A, Lee HJ, de Groot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020. PMID: 32484922.
- Triche L, Yarbrough A, Roth M, Ying A, Wells R. Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story. Pediatr Hematol Oncol 37(5):1-5, 2020. e-Pub 2020. PMID: 32347770.
- Harrison DJ, Gill JD, Roth ME, Zhang W, Teicher B, Erickson S, Gatto G, Kurmasheva RT, Houghton PJ, Smith MA, Kolb EA, Gorlick R. Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium. Pediatr Blood Cancer 67(6):e28222, 2020. e-Pub 2020. PMID: 32207565.
- Roth ME, Unger JM, O'Mara AM, Lewis MA, Budd T, Johnson RH, Pollock BH, Blanke C, Freyer DR. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era. Cancer Med 9(6):2146-2152, 2020. e-Pub 2020. PMID: 32009305.
- Raber M, Crawford K, Baranowski T, Sharma SV, Schick V, Markham C, Roth M, Wakefield CE, Chandra J. Meal planning values impacted by the cancer experience in families with school-aged survivors-a qualitative exploration and recommendations for intervention development. Support Care Cancer 28(3):1305-1313, 2020. e-Pub 2020. PMID: 31243584.
- Raber M, Crawford K, Baranowski T, Sharma SV, Schick V, Markham C, Roth M, Chandra J. Exploring food preparation practices in families with and without school-aged childhood cancer survivors. Public Health Nutr 23(3):410-415, 2020. e-Pub 2020. PMID: 31538553.
- Gill J, Hingorani P, Roth M, Gorlick R. HER2-Targeted Therapy in Osteosarcoma. Adv Exp Med Biol 1257:55-66, 2020. e-Pub 2020. PMID: 32483730.
- Kinnaman, MD, Zhu, C, Weiser, DA, Mohiuddin, S, Hingorani, P, Roth, M, Gill, JB, Janeway, K, Gorlick, R, Lessnick, SL, Grohar, P. Survey of paediatric oncologists and pathologists regarding their views and experiences with variant translocations in ewing and ewing-like sarcoma. Sarcoma 2020, 2020. e-Pub 2020. PMID: 33488267.
- Pecker LH, Silver EJ, Roth M, Manwani D. Pediatric Hematologists Report Infrequent Prognosis Discussions in the Routine Care of Children with Sickle Cell Disease. J Health Care Poor Underserved 31(1):398-423, 2020. e-Pub 2020. PMID: 32037339.
- Nevil G, Roth M, Gill J, Zhang W, Teicher B, Erickson SW, Gatto G, Smith M, Kolb EA, Gorlick R. Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium. Pediatr Hematol Oncol 38(1):1-6, 2020. e-Pub 2020. PMID: 32804009.
- Levine NL, Zhang Y, Hoang BH, Yang R, Jurkowski ZH, Roth ME, Gill JB, Lo Y, Eisenberg RE, Bekarev M, Gorlick R, Geller DS. LigaSure Use Decreases Intraoperative Blood Loss Volume and Blood Transfusion Volume in Sarcoma Surgery. J Am Acad Orthop Surg 27(22):841-847, 2019. e-Pub 2019. PMID: 30889038.
- Margiotoudi K, Marie D, Claidiere N, Coulon O, Roth M, Nazarian B, Lacoste R, Hopkins WD, Molesti S, Fresnais P, Anton JL, Meguerditchian A. Handedness in monkeys reflects hemispheric specialization within the central sulcus. An in vivo MRI study in right- and left-handed olive baboons. Cortex 118:203-211, 2019. e-Pub 2019. PMID: 30738569.
- Roth L, Moerdler S, Weiser D, Douglas L, Gill J, Roth M. Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses. Int J Pediatr Otorhinolaryngol 121:34-40, 2019. e-Pub 2019. PMID: 30861425.
- Gilchrist SC, Roth M, Livingston JA, Hildebrandt MAT, Kleinerman ES, Banchs J. Short-Term Changes in Cardiac Function in Osteosarcoma Patients Receiving Anthracyclines. J Adolesc Young Adult Oncol 8(3):385-386, 2019. e-Pub 2019. PMID: 30794081.
- Currier AW, Kolb EA, Gorlick RG, Roth ME, Gopalakrishnan V, Sampson VB. p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma. Sci Rep 9(1):6161, 2019. e-Pub 2019. PMID: 30992462.
- Moerdler S, Zhang L, Gerasimov E, Zhu C, Wolinsky T, Roth M, Goodman N, Weiser DA. Physician perspectives on compassionate use in pediatric oncology. Pediatr Blood Cancer 66(3):e27545, 2019. e-Pub 2019. PMID: 30408307.
- Andolina JR, Burke MJ, Hijiya N, Chaudhury S, Schultz KR, Roth ME. Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant 25(2):321-327, 2019. e-Pub 2019. PMID: 30267760.
- Geller, D, Levine, NL, Hoang, B, Yang, R, Weiser, DA, Morris, J, Gorlick, R, Gill, JB, Roth, M, Tingling, J, Brohl, AS. Genomic analysis does not support malignant transformation of osteoblastoma to osteosarcoma. JCO Precision Oncology 3:1-7, 2019. e-Pub 2019. PMID: 32914027.
- Zhang, Y, Zvi, YS, Batko, B, Zaphiros, N, O’Donnell, EF, Wang, J, Sato, K, Yang, R, Geller, D, Koirala, P, Zhang, W, Du, X, Piperdi, S, Liu, Y, Zheng, D, Roth, M, Gill, JB, Zhang, J, Ren, T, Gorlick, R, Zi, X, Hoang, B. Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma. Scientific reports 8(1), 2018. e-Pub 2018. PMID: 30250282.
- Malbari F, Spira M, B Knight P, Zhu C, Roth M, Gill J, Abbott R, Levy AS. Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis: Impact of Family History. J Pediatr Hematol Oncol 40(6):e359-e363, 2018. e-Pub 2018. PMID: 29683959.
- Zhu C, Olson KA, Roth M, Geller DS, Gorlick RG, Gill J, Laack NN, Randall RL. Provider views on the management of Ewing sarcoma of the spine and pelvis. J Surg Oncol 117(3):417-424, 2018. e-Pub 2018. PMID: 29044582.
- Shaul E, Roth M, Lo Y, Geller DS, Hoang B, Yang R, Malkin D, Gorlick R, Gill J. Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma. Cancer 124(6):1242-1250, 2018. e-Pub 2018. PMID: 29313943.
- Barris, DM, Weiner, SB, Dubin, RA, Fremed, M, Zhang, X, Piperdi, S, Zhang, W, Maqbool, S, Gill, JB, Roth, M, Hoang, B, Geller, D, Gorlick, R, Weiser, DA. Detection of circulating tumor DNA in patients with osteosarcoma. Oncotarget 9(16):12695-12704, 2018. e-Pub 2018. PMID: 29560102.
- Maxwell RR, Egan-Sherry D, Gill JB, Roth ME. Management of Chemotherapy-Induced Febrile Neutropenia in Pediatric Oncology Patients: A North American Survey of Pediatric Hematology/Oncology and Pediatric Infectious Disease Physicians. Pediatr Blood Cancer 64(12), 2017. e-Pub 2017. PMID: 28748605.
- Peterson HM, Hoang BH, Geller D, Yang R, Gorlick R, Berger J, Tingling J, Roth M, Gill J, Roblyer D. In vivo, noninvasive functional measurements of bone sarcoma using diffuse optical spectroscopic imaging. J Biomed Opt 22(12):1-9, 2017. e-Pub 2017. PMID: 29264893.
- Ren T, Piperdi S, Koirala P, Park A, Zhang W, Ivenitsky D, Zhang Y, Villanueva-Siles E, Hawkins DS, Roth M, Gorlick R. CD49b inhibits osteogenic differentiation and plays an important role in osteosarcoma progression. Oncotarget 8(50):87848-87859, 2017. e-Pub 2017. PMID: 29152125.
- Morris J, Yang R, Roth M, Gill J, Gorlick R, Lo Y, Hoang BH, Garfein E, Geller DS. Mechanical analysis of the vascularized fibular graft prosthetic composite (VFGPC) for internal hemipelvectomy reconstruction. J Surg Oncol 115(7):864-869, 2017. e-Pub 2017. PMID: 28543392.
- Gill J, Connolly P, Roth M, Chung SH, Zhang W, Piperdi S, Hoang B, Yang R, Guzik H, Morris J, Gorlick R, Geller DS. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis. PLoS One 12(3):e0173322, 2017. e-Pub 2017. PMID: 28264040.
- Yang Y, Yang R, Roth M, Piperdi S, Zhang W, Dorfman H, Rao P, Park A, Tripathi S, Freeman C, Zhang Y, Sowers R, Rosenblum J, Geller D, Hoang B, Gill J, Gorlick R. Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model. Genes Cancer 8(1-2):484-494, 2017. e-Pub 2017. PMID: 28435520.
- Cohen B, Roth M, Marron JM, Gray SW, Geller DS, Hoang B, Gorlick R, Janeway KA, Gill J. Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling. Ann Surg Oncol 23(Suppl 5):990-997, 2016. e-Pub 2016. PMID: 27459981.
- Geller DS, Morris J, Revskaya E, Kahn M, Zhang W, Piperdi S, Park A, Koirala P, Guzik H, Hall C, Hoang B, Yang R, Roth M, Gill J, Gorlick R, Dadachova E. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R). Nucl Med Biol 43(12):812-817, 2016. e-Pub 2016. PMID: 27744117.
- Weintraub L, Figueiredo L, Roth M, Levy A. The feasibility of implementing a communication skills training course in pediatric hematology/oncology fellowship. Pediatr Hematol Oncol 33(7-8):480-490, 2016. e-Pub 2016. PMID: 27922758.
- Koirala P, Roth ME, Gill J, Chinai JM, Ewart MR, Piperdi S, Geller DS, Hoang BH, Fatakhova YV, Ghorpade M, Zang X, Gorlick R. HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival. Sci Rep 6:31154, 2016. e-Pub 2016. PMID: 27531281.
- Koirala P, Roth ME, Gill J, Piperdi S, Chinai JM, Geller DS, Hoang BH, Park A, Fremed MA, Zang X, Gorlick R. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep 6:30093, 2016. e-Pub 2016. PMID: 27456063.
- Polishchuk V, Khazal S, Berulava G, Roth M, Mahadeo KM. 5-Azacitidine Monotherapy Followed by Related Haploidentical Hematopoietic Stem Cell Transplantation Achieves Durable Remission in a Pediatric Patient With Acute Undifferentiated Leukemia Refractory to High-Dose Chemotherapy. Pediatr Blood Cancer 63(6):1111-2, 2016. e-Pub 2016. PMID: 26914221.
- Roth ME, O'Mara AM, Seibel NL, Dickens DS, Langevin AM, Pollock BH, Freyer DR. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program. J Oncol Pract 12(4):e388-95, 2016. e-Pub 2016. PMID: 27026648.
- Roth M, Barris DM, Piperdi S, Kuo V, Everts S, Geller D, Houghton P, Kolb EA, Hawthorne T, Gill J, Gorlick R. Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma. Pediatr Blood Cancer 63(1):32-8, 2016. e-Pub 2016. PMID: 26305408.
- Will B, Vogler TO, Narayanagari S, Bartholdy B, Todorova TI, da Silva Ferreira M, Chen J, Yu Y, Mayer J, Barreyro L, Carvajal L, Neriah DB, Roth M, van Oers J, Schaetzlein S, McMahon C, Edelmann W, Verma A, Steidl U. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia. Nat Med 21(10):1172-81, 2015. e-Pub 2015. PMID: 26343801.
- Geller DS, Singh MY, Zhang W, Gill J, Roth ME, Kim MY, Xie X, Singh CK, Dorfman HD, Villanueva-Siles E, Park A, Piperdi S, Gorlick R. Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2. Clin Cancer Res 21(13):3003-12, 2015. e-Pub 2015. PMID: 25472999.
- Bhattasali O, Vo AT, Roth M, Geller D, Randall RL, Gorlick R, Gill J. Variability in the reported management of pulmonary metastases in osteosarcoma. Cancer Med 4(4):523-31, 2015. e-Pub 2015. PMID: 25626877.
- Poon VI, Roth M, Piperdi S, Geller D, Gill J, Rudzinski ER, Hawkins DS, Gorlick R. Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma. Clin Sarcoma Res 5(1):4, 2015. e-Pub 2015. PMID: 25642322.
- Pecker LH, Roth M, Landman S, Cunningham L, Silver EJ, Manwani D. Communicating Prognosis in Sickle Cell Disease: A Qualitative Study of Adolescents with Sickle Cell Disease, their Parents, and Providers. Ann Pediatr Child Health 3(1):1031, 2015. e-Pub 2015.
- Tamari R, Schinke C, Bhagat T, Roth M Braunschweig I, Will B, Steidl U, Verma A. Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone. Leuk Lymphoma 55(12):2901-6, 2014. e-Pub 2014. PMID: 24650011.
- Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, Strauchen J, Roth M, Wistinghausen B. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia. J Pediatr Hematol Oncol 36(8):e481-6, 2014. e-Pub 2014. PMID: 24878618.
- Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, Gill J, Gorlick R. Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer 120(4):548-54, 2014. e-Pub 2014. PMID: 24166473.
- Cao Y, Roth M, Piperdi S, Montoya K, Sowers R, Rao P, Geller D, Houghton P, Kolb EA, Gill J, Gorlick R. Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma. PLoS One 9(8):e106249, 2014. e-Pub 2014. PMID: 25170759.
- Kessel RM, Roth M, Moody K, Levy A. Day One Talk: parent preferences when learning that their child has cancer. Support Care Cancer 21(11):2977-82, 2013. e-Pub 2013. PMID: 23760458.
- Will B, Vogler TO, Bartholdy B, Garrett-Bakelman F, Mayer J, Barreyro L, Pandolfi A, Todorova TI, Okoye-Okafor UC, Stanley RF, Bhagat TD, Verma A, Figueroa ME, Melnick A, Roth M, Steidl U. Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nat Immunol 14(5):437-45, 2013. e-Pub 2013. PMID: 23563689.
- Roth M, Davies D, Friebert S, Wang D, Kim M, Zelcer S. Attitudes and practices of pediatric oncologists regarding methadone use in the treatment of cancer-related pain: results of a North American Survey. J Pediatr Hematol Oncol 35(2):103-7, 2013. e-Pub 2013. PMID: 23242323.
- Roth M, Krystal J, Manwani D, Driscoll C, Ricafort R. Stem cell transplant for children with sickle cell anemia: parent and patient interest. Biol Blood Marrow Transplant 18(11):1709-15, 2012. e-Pub 2012. PMID: 22659467.
- Kawahara M, Pandolfi A, Bartholdy B, Barreyro L, Will B, Roth M, Okoye-Okafor UC, Todorova TI, Figueroa ME, Melnick A, Mitsiades CS, Steidl U. H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia. Cancer Cell 22(2):194-208, 2012. e-Pub 2012. PMID: 22897850.
- Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, Tamari R, Mitsiades CS, Verma A, Steidl U. Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood 120(2):386-94, 2012. e-Pub 2012. PMID: 22627766.
- Roth M, Morrone K, Moody K, Kim M, Wang D, Moadel A, Levy A. Career burnout among pediatric oncologists. Pediatr Blood Cancer 57(7):1168-73, 2011. e-Pub 2011. PMID: 21548010.
- Roth M, Wang D, Kim M, Moody K. An assessment of the current state of palliative care education in pediatric hematology/oncology fellowship training. Pediatr Blood Cancer 53(4):647-51, 2009. e-Pub 2009. PMID: 19449397.
- Roth M, Lin J, Kim M, Moody K. Pediatric oncologists' views toward the use of complementary and alternative medicine in children with cancer. J Pediatr Hematol Oncol 31(3):177-82, 2009. e-Pub 2009. PMID: 19262243.
- Cutler CB, Legano LA, Dreyer BP, Fierman AH, Berkule SB, Lusskin SI, Tomopoulos S, Roth M, Mendelsohn AL. Screening for maternal depression in a low education population using a two item questionnaire. Arch Womens Ment Health 10(6):277-83, 2007. e-Pub 2007. PMID: 17710366.
- Robles JM, Ji L, Dressler E, Nightingale C, Kittel C, Salsman JM, Ghazal L, Murphy KM, Roth ME, Parsons SK, Beauchemin M. Financial Distress Screening and Financial Navigation Among Adolescents and Young Adults Within the National Cancer Institute Community Oncology Research Program: Results of the 2022 Landscape Survey. JCO Oncology Practice.
- Tonn T, Thawani M, Mazer M, Aune G, Kent D, Albritton K, Koutroumpaki E, Roth ME, Hildebrandt. Disparities in cardiovascular disease burden among Black and Hispanic survivors of adolescent and young adult. Cardio-Oncology.
- Wang Y, Zhang Z, Longo C, Zhang W, Wang Q, Najjar A, Tian X, Segura R, Roth ME, Gill JB, Harrison D, Xu Z, Yi Y, Zhou X, Jusu S, Stearns T, Neuhauser S, Bult C, Wang J, Lazar A, Gorlick R. Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models. Molecular Cancer Therapeutics.
- Moore R, Ahmad N, Kadosh M, Daniels R, Andersen C, Roth ME, Nelson K. Identifying Gaps and Needs in Care for Adolescents and Young Adults with Melanoma. Supportive Care in Cancer.
- Jafarnia J, Haff L, Moore R, Osheim A, Riley K, Zheng S, Roth ME, Salge M, Nelson K. Quality, Empathy, and Readability of AI Chatbot Responses to the Survivorship Needs of Adolescents and Young Adults With Melanoma: An Evaluation Study. JMIR Cancer.
- Ahmad N, Moore R, Andersen C, He Jiasen, Swartz M, Nelson, Roth ME. Patient-Reported Quality of Life in Adolescents and Young Adults with Melanoma. Supportive Care in Cancer.
- Freyer DS, Zhou DR, Roth ME, Wolfson JA, Meng Q, Agarwal R, Tang R, Bhagnani T. Survival outcomes with guideline-concordant pediatric-inspired regimens in adolescent/young adult acute lymphoblastic leukemia: retrospective real-world analysis. Drugs Real World Outcomes.
- Robert M, Saha S, Dizman N, Rohlfs M, Sirmans E, Simon J, Amaria R, Glitzo Oliva I, Tawbi H, Davies M, Ikeguchi A, Basen-Engquist K, Schadler K, Roth ME, Song W, Zhang X, Ajami N, Cohen L, Wargo J, Peterson C, McQuade J, Daniel C. Investigating chronic toxicity, diet, patient-reported outcomes 2 and the microbiome in immunotherapy-treated metastatic mela-3 noma survivors: a new frontier. Nutrients.
- Beauchemin M, Murphy-Banks R, Rodday AM, Freyer DR, Miller K, Fleisher E, Ohlsen T, Linendoll N, Chan R, Croswell H, Roth ME, Parsons SK. Factors influencing engagement in survivorship care among young adult survivors of hematologic malignancies: A mixed methods report. Supportive Care in Cancer.
- Hayek S, Miller K, Roth ME, Hildebrandt M, Freyer DR, Milam J. Social Roles and Emotional Distress Are Associated With Successful Aging in Adult Childhood Cancer Survivors. Scientific Reports.
- Cho D, Ahmed S, Snyder S, Kroll J, Chen M, Roth ME, Milbury K. Group-based support interventions for adolescents and young adults with lymphoma: A pilot randomized controlled trial. Psycho Oncology.
- Itzep NE, Moore J, Gallagher C, Roth ME, Martin P, Hernandez M, Moody KM. Adolescents’ and young adults’ perspectives on decision-making and the emotional experience of having advanced cancer. Journal of Pain and Symptom Management.
- Berkman AM, Tran M, Thompson L, Lerman C, Nieva J, Chi Y, Roth ME, Cockburn M, Freyer DR. Secondary Lung Cancer Among Survivors of Adolescent and Young Adult Cancer: A Population-Based Study. Cancer Epidemiol Biomarkers Prev.
- Catueno S, Frost M, Cuglievan B, Gibson A, McCall D, Nunex C, Roth ME, Malpica L, Garcia M. Uncommon Presentation and Therapeutic Strategies in Pediatric Relapsed/Refractory ALK-Positive ALCL. Journal of Pediatric Hematology Oncology.
- Cruz CA, Rodriguez E, Thawani M, Mazer M, Hayhurst M, Swanson M, Romero A, Livingston JA, Aune G, Kent D, Cuglievan B, Roth ME, Ahmed S, Albritton K, Hildebrandt M. Differences in time to treatment and impact on overall survival in adolescents and young adults with Hodgkin lymphoma. Leukemia & Lymphoma.
- Freyer DR, Haydon MD, Mobley EM, MAck W, Roth ME, Miller KA, Hamilton AS, Milam JE. Symptom burden among long-term survivors of young adult cancer: a report from the Project Milestones Cohort.
- Wu HW, Jumonville G, Beauchemin M, Roth ME, Pinheiro L. Healthcare Utilization and Communication Patterns among Survivors of Adolescent and Young Adult Cancer: Results from the Health Information National Trends Survey. Pediatric Blood & Cancer.
- Smith, Feldman D, Ma H, Checka C, Roth ME, Tucker J, Anderson C, Xavier M, Kagihara J, Ludmir E, Wu CF, Paredes E, Milbury K, Corn B. Financial Toxicity, Hope, and Satisfaction With Life in Patients Receiving Ambulatory Cancer Care. JAMA Network Open.
- Roth ME, Griffith W, Choi E, Yarbrough A, Bell D, Adams L, Corredor J, DeRousse H, Harris J, Blanc J, Parker C, Guzman D, Robinson M, Chernyshov A, Cheng J, Saldana A, Mistry H, Livingston JA. Development of a Multidisciplinary Adolescent and Young Adult Program at a Large Academic Cancer Center. JCO Oncology Practice.
- Corrigan K, Berkman A, Gunther J, Andersen C, Wu S, Gibson A, Cuglievan B, Garcia M, Manzar G, Fang P, De B, Ahmed S, Nunez C, Hildebrandt M, McCall D, Parsons S, Roth ME. Trends in Radiation Use from 2004-2020 Among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiology, Biomarkers & Prevention.
- Choi E, Xu Y, Wong CY, Roth ME, Li Y, Lu Q. Optimizing Feasibility and Acceptability of an Online Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer: A Pilot Randomized Trial of Iterative Modifications and Outcomes. Psycho oncology.
- He J, John I, Sun M, Andersen C, Wang Y, Roth ME, McQuade J. Patterns of Immune-Related Adverse Events and Treatment Responses in Adolescents and Young Adults with Melanoma During Initial and Rechallenge Immune Checkpoint Inhibitor Therapy. Journal of Immunotherapy in Cancer.
- Olsen TJD, Murphy-Banks R, Beauchemin M, Rodday AM, Freyer D, Miller KA, Fleisher E, Xiang Q, Lenendoll N, Chan RY, Crosswell HE, Roth ME, Parsons SK. Cancer-related impacts on employment and strategies for support among long-term young adult survivors of hematologic malignancies. JCO Oncology Practice.
- Haisraely O, Vedala S, Al-Sharfeen A, Manzar G, Perni S, Tom M, Beckham T, Wang C, Yeboa D, Chung C, McAleer M, Ghia A, Li J, Ene C, Weathers SP, McGovern S, Roth ME, De B. Glioblastoma in Young Adult Patients: Contemporary Patterns of Care and Survival in the United States. Journal of Neuro Oncology.
- Dupuis, Vettese, Aftandilian, Agarwal, Baggott, Brafield, Crelin, Freyer, Kelly, King, Kyono, Orgel, Roth ME, Grimes, Beauchemin, Klesges, Tomlinson, Sung. Factors Associated with Self- report Symptom Screening Adherence in Pediatric Cancer Patients. Cancer Medicine.
- Berkman A, Andersen C, Puthenpura V, Short N, Merriman K, Swaminathan M, Cuglievan B, McCall D, DiNardo C, Nunez C, Jain N, Kadia T, Issa G, Gibson A, Garcia M, Livingston JA, Parsons S, Hildebrandt M, Roth ME. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectrum.
- Yan A, Dupuis L, Aftandilian C, Agarwal V, Baggott C, Beauchemin M, Bradfield S, Cannone D, Caywood E, Roth ME, Sherani F, Vettese E, Walsh A, Woods-Swafford W, Yu L, Tomlinson G, Sung L. Factors Associated with Symptom Burden among Pediatric Patients with Cancer. JCO Oncology Practice.
- Lau N, Srinakarin K, Hon S, Aalfs H, Roth ME, Murphy K, Berkman A, Chan S, Patten J, Iwata W, Taylor M, Fann J, Chow E, Palermo T. Mobile Health App Attitudes and Adoption Among Oncology Providers: Cross-Sectional National Survey. JMIR Internet Research.
- Jiminez-Rivero M, Poche A, Haushalter K, Hudson E, Larson D, Nikah K, Garcia M, Roth ME, Davis J, Chandra J. Cook-Grow!: Insights from a Pilot Study on a Virtual Cooking, Gardening, and Nutrition Education Program for Childhood Cancer Survivors and their Families. Journal of Cancer Education.
Review Articles
- Propst, CL, Sucholeiki, RL, Chandra, J, Livingston, JA, Roth, M, Hong, DS, George, GC. Diet in adolescent and young adult patients with cancer and cancer survivors. Supportive Care in Cancer 33(6), 2025. e-Pub 2025. PMID: 40411574.
- Propst C, Sucholeiki R, Chandra J, Livingston JA, Roth ME, Hong DS, George G. Diet in Adolescent and Young Adult Cancer Patients and Survivors: A Scoping Review. Supportive Care in Cancer. e-Pub 2025.
- Roth, M, Hawkins, DS, Merrill, JK, Henderson, TO. Childhood Cancer-Connect. Journal of the National Cancer Institute 117(2):229-239, 2025. e-Pub 2025. PMID: 39254627.
- Greenzang K, Montgomery K, DuVall A, Roth ME, Krailo M, Nuno M, Renfro L, DelRocco N, Doski J, Kelly K, Castellino S, Reed D, Janeway K, Hinds P, Zupanec S, Parsons S. Incorporation of Patient-Reported Outcomes in Pediatric Cancer Clinical Trials: Design, Implementation, and Dissemination. JNCI. e-Pub 2025.
- Cheung, CK, Lee, H, Francis-Levin, N, Choi, E, Geng, Y, Thomas, BN, Roman, VA, Roth, M. Provider preparedness to care for sexual and gender minority adolescent and young adult cancer patients: A scoping review. PEC Innovation 5:100343, 2024. e-Pub 2024. PMID: 39346774.
- Hesko, C, Heath, JL, Roth, M, Mittal, N. Sharing is caring. Hematology (United States) 2024(1):27-33, 2024. e-Pub 2024. PMID: 39643982.
- Berkman AM, Betts AC, Beauchemin M, Parsons SK, Freyer DR, Roth ME. Survivorship after adolescent and young adult cancer: Models of care, disparities, and opportunities. J Natl Cancer Inst 116(9):1417-1428, 2024. e-Pub 2024. PMID: 38833671.
- Cuglievan B, Kantarjian H, Rubnitz JE, Cooper TM, Zwaan CM, Pollard JA, DiNardo CD, Kadia TM, Guest E, Short NJ, McCall D, Daver N, Nunez C, Haddad FG, Garcia M, Bhalla KN, Maiti A, Catueno S, Fiskus W, Carter BZ, Gibson A, Roth M, Khazal S, Tewari P, Abbas HA, Bourgeois W, Andreeff M, Shukla NN, Truong DD, Connors J, Ludwig JA, Stutterheim J, Salzer E, Juul-Dam KL, Sasaki K, Mahadeo KM, Tasian SK, Borthakur G, Dickson S, Jain N, Jabbour E, Meshinchi S, Garcia-Manero G, Ravandi F, Stein EM, Kolb EA, Issa GC. Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
- He J, Munir F, Catueno S, Connors JS, Gibson A, Robusto L, McCall D, Nunez C, Roth M, Tewari P, Garces S, Cuglievan B, Garcia MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers (Basel) 16(5), 2024. e-Pub 2024. PMID: 38473221.
- Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.
- Caru M, Wurz A, Brunet J, Barb ED, Adams SC, Roth ME, Winters-Stone K, Fidler-Benaoudia MM, Dandekar S, Ness KK, Culos-Reed SN, Schulte F, Rao P, Mizrahi D, Swartz MC, Smith M, Valle CG, Kadan-Lottick NS, Dieli-Conwright CM, Schmitz KH, with Cancer NACOEIAD. Physical activity and physical fitness assessments in adolescents and young adults diagnosed with cancer: a scoping review. Support Care Cancer 31(10):569, 2023. e-Pub 2023. PMID: 37695526.
- Murphy KM, Siembida E, Lau N, Berkman A, Roth M, Salsman JM. A Systematic Review of Health-related Quality of Life Outcomes in Psychosocial Intervention Trials for Adolescent and Young Adult Cancer Survivors. Crit Rev Oncol Hematol 188:104045, 2023. e-Pub 2023. PMID: 37269881.
- Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Andring LM, Geng Y, Kouzy R, Livingston JA, Peterson SK, Bishop AJ, Smith GL, Gunther JR, Parsons SK, Roth M. Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: a scoping review. Support Care Cancer 31(4):230, 2023. e-Pub 2023. PMID: 36961516.
- Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Transl Pediatr 12(3):487-502, 2023. e-Pub 2023. PMID: 37035397.
- Berkman AM, Mittal N, Roth ME. Adolescent and young adult cancers: unmet needs and closing the gaps. Curr Opin Pediatr 35(1):84-90, 2023. e-Pub 2023. PMID: 36592027.
- Smith GL, Banegas MP, Acquati C, Chang S, Chino F, Conti RM, Greenup RA, Kroll JL, Liang MI, Pisu M, Primm KM, Roth ME, Shankaran V, Yabroff KR. Navigating financial toxicity in patients with cancer: A multidisciplinary management approach. CA Cancer J Clin 72(5):437-453, 2022. e-Pub 2022. PMID: 35584404.
- Itzep N, Roth M. Psychosocial Distress Due to Interference of Normal Developmental Milestones in AYAs with Cancer. Children (Basel) 9(3), 2022. e-Pub 2022. PMID: 35327680.
- Sheikh IN, Roth M, Stavinoha PL. Prevalence of Sleep Disturbances in Pediatric Cancer Patients and Their Diagnosis and Management. Children (Basel) 8(12), 2021. e-Pub 2021. PMID: 34943294.
- Siembida EJ, Loomans-Kropp HA, Trivedi N, O'Mara A, Sung L, Tami-Maury I, Freyer DR, Roth M. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention. Cancer 126(5):949-957, 2020. e-Pub 2020. PMID: 31869454.
- Murphy, BR, Roth, M, Kolb, EA, Alonzo, TA, Gerbing, RB, Wells, RJ. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome. Pediatric Blood and Cancer 66(8), 2019. e-Pub 2019. PMID: 30908863.
- Bailey K, Roth M, Weiser D, Gill J. High-Dose Chemotherapy with Stem Cell Rescue in Desmoplastic Small Round Cell Tumor: A Single-Institution Experience and Review of the Literature. Sarcoma 2018:1948093, 2018. e-Pub 2018. PMID: 29853779.
- Pathak S, Roth M, Verma A, Steidl U. Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders. Expert Opin Drug Metab Toxicol 9(12):1667-75, 2013. e-Pub 2013. PMID: 24215532.
- Roth M, Manwani D. Thrombotic disorders. Pediatr Rev 32(1):41-3, 2011. e-Pub 2011. PMID: 21196507.
Other Articles
- Roth, M, Berkman, AM Mortality in survivors of adolescent and young adult cancer. The Lancet Public Health 10(1):e8-e9, 2025. PMID: 39755416.
- Levy, AS, Roth, M, Morrone, K, Moody, K Feel the fear, but do it anyway. Journal of palliative medicine 13(12):1492-1493, 2010. PMID: 21155648.
- Berkman AM, Andersen C, Dixon S, Ramirez A, Gilmore K, Thoman W, Razouki Z, Santos D, Thosani S, Livingston JA, Hildebrandt M, Roth ME Weight-Related Outcomes among Survivors of Adolescent and Young Adult Cancer after Anti-Obesity Medication Initiation. JAYAO.
Editorials
- Okeleji, O, McCall, DC, Gibson, A, Garcia, MB, Nunez, CA, Roth, M, Connors, JS, Petropoulos, D, Tewari, P, Cuglievan, B, Sheikh, IN. Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Advances 9(8):1988-1990, 2025. PMID: 39993239.
- Okeleji O, Gibson A, Nunez C, Garcia MB, Roth M, Cuglievan B, McCall D. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen. Pediatr Blood Cancer 71(8):e31091, 2024. PMID: 38840433.
- Berkman A, Roth ME, Livingston JA. Metastatic Disease at Presentation and Recurrence in AYA Cancer: Addressing a Key Driver of Early Mortality. JAMA Oncology.
Book Chapters
- Polishchuck V, Roth ME, Kolb EA. Childhood Leukemia. In: AAP Textbook of Primary Care: American Academy of Pediatrics, 6th Edition. AAP Textbook of Primary Care 6th Edition.
- Freyer D, Amy Berkman, Jones B, Jennifer Levine, Karim Sadak, Roth ME. Adolescents and Young Adults with Cancer and Transitional Care to Adulthood. In: Principles and Practice of Pediatric Oncology.
- Gill J, Hingorani P, Roth M, Gorlick R. HER-2 Targeted Therapy in Osteosarcoma. In: Current Advances in Osteosarcoma.
Letters to the Editor
- Nash, A, Dinh, CN, Kawedia, J, McCall, DC, Weinman, S, Garcia, M, Roth, M, Nunez, CA, Cuglievan, B, Gibson, A. Calasparagase Pegol Induced Hemolytic Anemia. Pediatric Blood and Cancer 72, 2025.
- Nasnas P, Ling J, Gerstein Y, Wang SA, Loghavi S, Hammond D, Montalban-Bravo G, Senapati J, Pemmaraju N, Corredor J, Pierce S, Roth M, Ravandi F, Cuglievan B, Kadia T, DiNardo CD. Detection of PNH Clones can Aid in the Distinction of Aplastic Anemia vs Inherited BM Failure Syndromes: A Single Center Experience and Review of the Literature. Clin Lymphoma Myeloma Leuk 24: 732-735, 2024.
- Sheikh IN, AlQahtani S, Yin CC, McCall D, Cuglievan B, Ragoonanan D, Connors JS, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatr Blood Cancer 71: e30898, 2024.
- Geller, D, Gill, JB, Roth, M, Gorlick, R. To B(MP-2) or Not To B(MP-2). Clinical Cancer Research 21: 4022, 2015.
- Raj R, Catueno S, Gibson A, McCall D, Garcia M, Nunez C, Roth ME, Sasaki K, Tewari P, Issa G, Farhat A, Connors J, Bhalla K, Petropoulos D, Daver N, Kadia T, Cuglievan B, DiNardo C. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. Blood.
- Catueno S, Ramakrishnan R, Elitzur S, Garcia M, McCall D, Nunez C, Roth ME, Cuglievan B, Gibson A. Lymphoid Malignancies in Ataxia-Telangiectasia: Experience with Novel Targeted Therapies. Pediatric Blood and Cancer.
Patient Reviews
CV information above last modified March 06, 2026